Intravascular membrane oxygenator catheter with oscillating hollow fiber membranes

ABSTRACT

The present disclosure describes intravascular oxygenation systems and methods with one or more of improved oxygen diffusion flux, improved resistance to bubble formation on the surface of non-porous hollow fibers, and reduced size. The systems and methods include a pneumatic inlet coupled to a pneumatic source that provides a gas containing oxygen at a high pressure. A plurality of hollow fiber membranes (HFM) are in pneumatic communication with the pneumatic inlet to receive the gas containing oxygen and with an outlet to exhaust a partially deoxygenated gas. An electronic controller drives the motor to oscillate the plurality of HFMs to cause a diffusive flux of the gas containing oxygen from the plurality of HFMs into a region of interest of a subject. The electronic controller may drive the motor according to an oscillation pattern, which may include a macro-oscillation with superimposed micro-oscillations.

RELATED APPLICATIONS

The present application is based on and claims priority from U.S. PatentApplication No. 63/254,208, filed on Oct. 11, 2021, the entiredisclosure of which is incorporated herein by reference.

FEDERAL FUNDING LEGEND

This invention was made with government support under Federal Grantno.1T32HD094671-01A1 awarded by the National Institute of Child Healthand Human Development (NIH/NICHHD). The government has certain rights tothis invention.

BACKGROUND

Acute respiratory failure with inadequate oxygenation and/or ventilationis a common reason for intensive care unit (ICU) admission in childrenand adults. When mechanical ventilation fails to adequately oxygenate apatient, other oxygenation systems may be used. One potential option isveno-venous extracorporeal membrane oxygenation (VV-ECMO). ECMO directlyoxygenates blood independent of the lungs and, therefore, is capable offully supporting a patient regardless of degree of lung injury.

SUMMARY

Veno-venous extracorporeal membrane oxygenation (VV-ECMO or ECMO) usedfor directly oxygenating blood is associated with potentialcomplications, including hemorrhage, thrombosis, and, infection.Further, ECMO is only available in approximately 9% of hospitals in theUnited States and fewer worldwide. The complexity and expense of ECMO,its associated morbidity, and its low availability limit the benefits ofthis potentially life-saving technology. There is a need for alternativetechnologies that support patients with severe respiratory failure thatfunction independently of diseased lungs. In this light, novel therapiessuch as an intravascular gas exchange device are an attractive option.Previous systems developed for intravascular oxygenation have beenunsuccessful due to, among other reasons, their reliance on a largesurface area to generate significant gas exchange which resulted inbulky catheters too large for intravascular use.

Systems and methods described herein are able to provide intravascularoxygenation for patients and overcome challenges presented by EMCO andother intravascular oxygenation systems using a combination of (i)high-pressure oxygenated gas (e.g., at or above 1.1 bar absolutepressure, between 1.1 bar and 2.0 bar of absolute pressure, or between1.1 bar 5.0 bar absolute pressure) to generate a large driving gradientacross a non-porous diffusing surface of hollow fiber membranes and (ii)angular or rotational oscillations of the HFMs to further enhance theoxygen transfer efficiency. Additionally, the rotational oscillationsmay include micro-oscillations superimposed on macro-oscillations. Bycombining the high-pressure oxygen gradient across non-porous HFMsundergoing angular oscillation, particularly with superimposedmicro-oscillations, the impacts of both internal and external barriersto oxygen mass transfer are reduced and high oxygen transferefficiencies are achieved for clinically significant intravascularoxygen delivery.

Oxygenation systems and methods provided herein use hyperbaricintraluminal oxygen pressure, which enables high diffusion through HFMs,combined with oscillations of the HFMs that increase the efficiency ofthe diffusion through the HFMs relative to static HFMs. In someexamples, micro-oscillations are superimposed on the oscillations (i.e.,on oscillations of larger angles, also referred to asmacro-oscillations), which can ensure that oxygen in the HFMs that isdiffused through the HFMs is dissolved into solution (into a subject'sblood) with decreased or no bubble formation. Because these oscillationtechniques decrease or eliminate bubbles, the HFMs can operate athyperbaric pressure and at higher levels than previously employable.Further, because higher pressure levels can be used, an increase inoxygen flux and transfer efficiency results. Further, the increasedoxygen flux and transfer efficiency (using hyperbaric pressure andoscillation) enables reduction in gas diffusing surface area of theHFMs. In other words, the size of the HFM bundle may be more compactand, thus more amenable to intravascular use.

Some embodiments of the disclosure provide an oxygenation system. Theoxygenation system can include a pneumatic inlet, a plurality of hollowfiber membranes (HFMs), a motor, and an electronic controller. Thepneumatic inlet can be configured to couple to a pneumatic source thatprovides a gas containing oxygen at a pressure at or above 1.1 bar ofabsolute pressure. The plurality of HFMs can be in pneumaticcommunication with the pneumatic inlet to receive the gas containingoxygen. The motor can be coupled to the plurality of HFMs. Theelectronic controller can be coupled to the motor and can be configuredto drive the motor to oscillate the plurality of HFMs to cause adiffusive flux of the gas containing oxygen from an interior of theplurality of HFMs in a region of interest of a subject.

Some embodiments of the disclosure provide a method for intravascularoxygenation. The method can include receiving, by a pneumatic inletcoupled to a pneumatic source, a gas containing oxygen at a pressure ator above 1.1 bar of absolute pressure, receiving, by a plurality ofhollow fiber membranes (HFMs) in pneumatic communication with thepneumatic inlet, the gas containing oxygen, and driving, by anelectronic controller, a motor to oscillate the plurality of HFMs tocause a diffusive flux of the gas containing oxygen from an interior ofthe plurality of HFMs in a region of interest of a subject.

The Summary is provided to introduce a selection of concepts that arefurther described below in the Detailed Description. This Summary is notintended to identify key or essential features of the claimed subjectmatter, nor is it intended to be used as an aid in limiting the scope ofthe claimed subject matter.

BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings, which are incorporated in and form a part ofthis specification, illustrate embodiments of the disclosure and,together with the description, explain principles of the embodiments.

FIG. 1A is a schematic diagram of an intravascular oxygenation systemaccording to some embodiments of this invention.

FIG. 1B is a cross-sectional view of a catheter lumen containing hollowfiber membranes (HFMs) of the oxygenation system of FIG. 1 .

FIG. 2A is a schematic diagram of another intravascular oxygenationsystem according to some embodiments of this invention.

FIG. 2B is an illustration of another aspect of the intravascularoxygenation system of FIG. 2A with a protective guard.

FIG. 2C is a cross-sectional view of the intravascular oxygenationsystem of FIG. 2B with a protective guard

FIG. 3A shows a perspective view of the catheter of FIG. 2C without aprotective guard and in a compressed configuration.

FIG. 3B shows a perspective view of the catheter of FIG. 2C in adeployed configuration.

FIGS. 4A and 4B illustrate a magnified view of a distal end of thecatheter of FIG. 2B in a compressed state and a deployed state,respectively.

FIG. 5 illustrates another magnified view of the distal end of thecatheter of FIG. 2B with a protective guard.

FIG. 6 illustrates a magnified view of a distal end of a catheteraccording to another embodiment including an independent rotationaldevice.

FIG. 7A illustrates a magnified view of a proximal end of the catheterof FIG. 2B.

FIG. 7B is a schematic diagram of a double lumen central shaftexchanging gas in an oxygenation system.

FIG. 7C is a magnified view of a proximal end of a catheter with ashared lumen in an oxygenation system according to some embodiments.

FIG. 8 is a flow chart of a method of intravascular oxygenation.

FIGS. 9A-9D illustrate an oscillation pattern according to someembodiments.

FIGS. 9E-9H illustrate another oscillation pattern according to someembodiments.

FIG. 10 illustrates an oscillation pattern in the form of a plot ofrotation angle versus time.

FIGS. 11A-11K illustrate further examples of rotational oscillationpatterns in the form of plots of rotation angle versus time.

FIG. 12 illustrates another catheter according to some embodimentsincluding a protective sheath.

FIG. 13 illustrates another catheter according to some embodimentsincluding a flexible joint and a micro-axial pump.

FIG. 14 is an illustration of a cross-sectional view of a spacingmechanism for HFMs.

FIG. 15A is an example illustration of a scooping configuration of thespacing mechanism of FIG. 14 .

FIG. 15B is an example illustration of a squeezing configuration of thespacing mechanism of FIG. 14 .

FIG. 16 is an example of a sawtooth rotational oscillation pattern thatcauses the HFMs to realize deployed scooping states and compressedsqueezing states.

FIGS. 17A-17I illustrate various configurations of the spacing mechanismaccording to some embodiments.

FIG. 18 is a schematic diagram of an experimental circuit used for HFMexperimentation using water.

FIG. 19 is a chart of experimentally determined oxygen flux at selectedangular speeds of oscillation and pressure.

FIG. 20 is a chart of an experimentally determined number of bubbles fora single loop of fiber in an aqueous solution.

FIG. 21 is a chart of experimentally determined oxygen flux of a hollowfiber member (HFM) bundle prototype undergoing superimposed angularoscillation.

FIG. 22 is a chart of experimentally determined normalized index ofhemolysis of a hollow fiber bundle prototype undergoing superimposedangular oscillations.

FIG. 23 is a process schematic of a benchtop experimental setup fortesting in porcine blood.

DETAILED DESCRIPTION

For the purposes of promoting an understanding of the principles of thepresent disclosure, reference will now be made to preferred embodimentsand specific language will be used to describe the same. It willnevertheless be understood that no limitation of the scope of thedisclosure is thereby intended, such alteration and furthermodifications of the disclosure as illustrated herein, beingcontemplated as would normally occur to one skilled in the art to whichthe disclosure relates.

Articles “a” and “an” are used herein to refer to one or to more thanone (i.e. at least one) of the grammatical object of the article. By wayof example, “an element” means at least one element and can include morethan one element.

“About” is used to provide flexibility to a numerical range endpoint byproviding that a given value may be “slightly above” or “slightly below”the endpoint without affecting the desired result.

The use herein of the terms “including,” “comprising,” or “having,” andvariations thereof, is meant to encompass the elements listed thereafterand equivalents thereof as well as additional elements. As used herein,“and/or” refers to and encompasses any and all possible combinations ofone or more of the associated listed items, as well as the lack ofcombinations where interpreted in the alternative (“or”).

As used herein, the transitional phrase “consisting essentially of” (andgrammatical variants) is to be interpreted as encompassing the recitedmaterials or steps “and those that do not materially affect the basicand novel characteristic(s)” of the claimed invention. Thus, the term“consisting essentially of” as used herein should not be interpreted asequivalent to “comprising.”

Moreover, the present disclosure also contemplates that in someembodiments, any feature or combination of features set forth herein canbe excluded or omitted. To illustrate, if the specification states thata complex comprises components A, B and C, it is specifically intendedthat any of A, B or C, or a combination thereof, can be omitted anddisclaimed singularly or in any combination.

Recitation of ranges of values herein are merely intended to serve as ashorthand method of referring individually to each separate valuefalling within the range, unless otherwise indicated herein, and eachseparate value is incorporated into the specification as if it wereindividually recited herein. For example, if a concentration range isstated as 1% to 50%, it is intended that values such as 2% to 40%, 10%to 30%, or 1% to 3%, etc., are expressly enumerated in thisspecification. These are only examples of what is specifically intended,and all possible combinations of numerical values between and includingthe lowest value and the highest value enumerated are to be consideredto be expressly stated in this disclosure.

As used herein, “treatment,” “therapy” and/or “therapy regimen” refer tothe clinical intervention made in response to a disease, disorder orphysiological condition manifested by a patient or to which a patientmay be susceptible. The aim of treatment includes the alleviation orprevention of symptoms, slowing or stopping the progression or worseningof a disease, disorder, or condition and/or the remission of thedisease, disorder or condition.

Furthermore, the disclosed subject matter may be implemented as asystem, method, apparatus, or article of manufacture using standardprogramming and/or engineering techniques and/or programming to producehardware, firmware, software, or any combination thereof to control anelectronic based device to implement aspects detailed herein.

Unless specified or limited otherwise, the terms “connected,” and“coupled” and variations thereof are used broadly and encompass bothdirect and indirect mountings, connections, supports, and couplings.Further, “connected” and “coupled” are not restricted to physical ormechanical connections or couplings. As used herein, unless expresslystated otherwise, “connected” means that one element/feature is directlyor indirectly connected to another element/feature, and not necessarilyelectrically or mechanically. Likewise, unless expressly statedotherwise, “coupled” means that one element/feature is directly orindirectly coupled to another element/feature, and not necessarilyelectrically or mechanically.

As used herein, the term “processor” may include one or more processorsand memories and/or one or more programmable hardware elements. As usedherein, the term “processor” is intended to include any of types ofprocessors, CPUs, microcontrollers, digital signal processors, or otherdevices capable of executing software instructions.

As used herein, the term “memory” includes a non-volatile medium, e.g.,a magnetic media or hard disk, optical storage, or flash memory; avolatile medium, such as system memory, e.g., random access memory (RAM)such as DRAM, SRAM, EDO RAM, RAMBUS RAM, DR DRAM, etc.; or aninstallation medium, such as software media, e.g., a CD-ROM, or floppydisks, on which programs may be stored and/or data communications may bebuffered. The term “memory” may also include other types of memory orcombinations thereof.

The term “flux” or “diffusive flux” refers to Fick's diffusion laws thata flux goes from regions of high concentration to regions of lowconcentration, with a magnitude that is proportional to theconcentration gradient (spatial derivative). In simplistic terms,diffusive flux refers to the concept that a solute will move from aregion of high concentration to a region of low concentration across aconcentration gradient. The flux or diffusive flux can be measured as atransmission rate from the region of high concentration to the region oflow concentration, in some aspects in milliliters (mL) per minute. In anon-limiting aspect, the flux or diffusive flux can be measured as atransmission rate from the inside of a device as described herein into avolume of water or a volume of blood. Flux or diffusive flux can bequantified by measuring dissolved oxygen. In fact, dissolved oxygen bydefinition only includes flux that is dissolved in solution and is not abubble. However, using a dissolved oxygen (DO) probe does not indicateif there are or aren't bubbles, it just indicates the amount of oxygenthat is dissolved.

The term “nonporous” refers to a solid wall that does not allow directcommunication from an interior side of the nonporous wall across orthrough it to an exterior side of the wall, allowing molecular transportonly via diffusion rather than convection. Nonporous means there are nopores, even at the nano, pico, or atto scale, and the solid wall iscontinuous such that the material of the solid wall has nodiscontinuities. The term “porous” refers to a wall having pores thatallow convection from an interior side of the porous wall through thepores to an exterior side of the wall. The pores in the porous wall havea diameter at or above approximately 0.1 microns to 1 micron, the poresin the porous wall can also have a diameter of 0.05 microns to 0.1micron or smaller. A pore could also be defined as a discontinuity inthe material comprising the wall, and the term porous can encompassterms such as “microporous” since this term refers to a porous or amaterial having discontinuity.

The term “effective amount” or “therapeutically effective amount” refersto an amount sufficient to effect beneficial or desirable biologicaland/or clinical results.

As used herein, the term “subject” and “patient” are usedinterchangeably herein and refer to both human and nonhuman animals. Theterm “nonhuman animals” of the disclosure includes all vertebrates,e.g., mammals and non-mammals, such as nonhuman primates, sheep, dog,cat, horse, cow, chickens, amphibians, reptiles, and the like. In someembodiments, the subject comprises a human who is undergoing a bloodoxygenation procedure using the systems and methods described herein.

Unless otherwise defined, all technical terms used herein have the samemeaning as commonly understood by one of ordinary skill in the art towhich this disclosure belongs.

The present disclosure builds upon the membrane oxygenation described inU.S. patent application Ser. No. 15/950,517 (Intravascular MembraneOxygenator Catheter Systems and Methods), incorporated herein byreference. The previously disclosed solution utilizes high pressureoxygen provided through small non-porous hollow fiber membranes (HFMs)to generate a large transmural gradient for diffusion, which results ina high mass transfer efficiency. However, under certain operatingconditions that generate a high oxygen flux, small oxygen bubbles havebeen noted to form on the abluminal surface of the HFMs. Generally,bubbles (or gaseous emboli) are not desired in a bloodstream becausebubbles can block small capillaries throughout the body, therebydecreasing blood flow (for example, in the pulmonary capillarieslimiting blood flow to the lungs), and because bubbles may induceinflammation and activate clotting within the bloodstream. The presentdisclosure addresses these and other challenges by providing systems andmethods to further enhance oxygen mass transfer efficiency whilelimiting the formation of bubbles on the abluminal surface of the HFMs.

For example, one aspect of the present disclosure provides anintravascular oxygenation system and method with improved oxygendiffusion flux and bubble reduction through oscillation of HFMs of thesystem. More particularly, in some examples, an intravascularoxygenation system is provided with a pneumatic inlet and outlet, aplurality of hollow fiber membranes (HFMs), a motor, and an electroniccontroller. The electronic controller can be coupled to the motor andconfigured to drive the motor to oscillate the plurality of HFMs tocause (or increase) a diffusive flux of a gas containing oxygen receivedat the pneumatic inlet from the plurality of HFMs into a region ofinterest of a subject. In some examples, the oscillation of the HFMsincludes rotational oscillation with micro-oscillations superimposed onmacro-oscillations, which can further reduce bubble generation in anoxygenation system. Generally, as pressure of the oxygenated gas in theHFMs 34 increases, diffusive flux of oxygen increases and bubbleformation increases. However, oscillating the HFMs, particularlyrotationally oscillating the HFMs with micro-oscillations superimposedon macro-oscillations, reduces the bubble formation, thereby enabling anincrease in the pressure of the oxygenated gas and in the resultingdiffusive flux of oxygen into blood without the corresponding increasein bubbles.

The improved resistance to bubble formation (and improved oxygen flux)can be attributed to one or more underlying mechanisms related to theoscillation of the HFMs. For example, oscillation causing the movementof HFMs in a direction perpendicular to blood flow can create a highereffective shear flow that reduces the opportunity for bubble formation.The oscillations have been shown to disturb blood boundary layerformation around each individual HFM allowing more oxygen to bedissolved. Moreover, even if microbubbles form on the surface of theHFM, the microbubble are disrupted by the oscillatory movement of theHFMs and swept away into the bloodstream to be dissolved prior tocoalescing into larger clinically significant bubbles. Additionally,oscillating the HFMs using superimposed angular oscillations canincrease convective mixing by disrupting secondary flow patterns of theblood and increase the relative velocity of blood flowing past the HFM,which can reduce liquid boundary layer formation. These mechanisms bothserve to reduce bubble formation and increase oxygen flux. Also,superimposed angular oscillations can induce movement such that the HFMsmay have less opportunity for fiber-to-fiber contact in the vascularpath, which could otherwise reduce efficiency. Further, the oscillationsmay induce vibrations along the fiber, and/or the motion of theoscillator can also directly or indirectly create a longitudinal wavealong the length of the HFM, either or both of which may dislodgemicroscopic bubbles before they grow in size, increase convectivemixing, and reduce liquid boundary layer formation.

FIG. 1A shows an intravascular oxygenation system 100 according to anaspect of the disclosure. The oxygenation system 100 can include acatheter 20 a (also referred to as catheter 20) that further includes acatheter shaft 22 extending from a proximal end 24 to a distal end 26along a longitudinal axis 28 to define a lumen 30. The catheter 20 a isconnected to a pneumatic source 32 in pneumatic communication with thecatheter 20 a at the proximal end 24. The pneumatic source 32 may be ahigh-pressure source of gas containing oxygen that may be pressure,flow, and temperature regulated to supply regulated gas containingoxygen to the catheter 20 a. In some non-limiting aspects, the pneumaticsource 32 can be a pneumatic tank, such as a medical grade oxygen tank.In other non-limiting aspects, the pneumatic source 32 can be apneumatic pump. The pneumatic source 32 is in pneumatic communicationwith a pneumatic control system 50. The pneumatic control system 50 mayinclude one or more valves to control the flow of gas from the pneumaticsource 32 to and the catheter 20 a and from the catheter 20 a to anambient environment of the system 50.

The lumen 30 of the catheter shaft 22 is configured to receive aplurality of hollow fiber membrane loops (HFMs) 34 of the catheter 20 athat are in pneumatic communication with the pneumatic source 32 via thepneumatic control system 50 via a pneumatic inlet 36 configured toprovide high pressure gas containing oxygen to the HFMs 34. The HFMs 34may be supported by a manifold 42 of the catheter shaft 22 that extendsinto the lumen 30 and provides a plurality of openings to receive theHFMs 34 such that the HFMs 34 may be retained or thermoset in themanifold 42 of the lumen 30. The HFMs 34 may also be retained orthermoset in a manifold at the proximal end 24 of the catheter shaft 22and then travel within catheter shaft 22 exiting at the distal end 26through manifold 42. In some non-limiting aspects, the HFMs 34 can beretained in the manifold 42 using a high strength epoxy or othersuitable materials for securely potting the HFMs 34 in the manifold 42.In some examples, spacers (e.g., wire spacers) are included in thecatheter 20 a and/or the bundle of HFMs 34 to space out HFMs 34, or theHFMs 34 may have intrinsic memory so that when the HFMs 34 are deployedwithin a vasculature of a subject, the HFMs 34 can spread out into aspaced configuration. Such spacers may also be provided in otherembodiments of the catheter 20 described below.

In some embodiments of the present disclosure, the HFMs 34 can be loopedsuch that an inlet side is connected to the pneumatic source 32 via thepneumatic inlet 36 and the inlet side can extend to the distal end 26 ofthe catheter 20 a where the inlet side transitions to the return side ofthe HFMs 34. The return side of the HFMs 34 can pneumaticallycommunicate with an outlet 38 that can communicate pneumatic exhaust outof the proximal end 24 of the catheter 20 a. The HFMs 34 can be arrangedin parallel loops with both ends retained in the manifold 42. In otherembodiments, such as described below, the individual HFMs of the bundleof HFMs 34 are not provided in a looped configuration such that an inletand outlet side of each HFM are on opposite ends (distal and proximalends) of the HFM bundle 34.

The oxygenation system 100 further includes an electronic controller 12.The electronic controller 12 is coupled to one or more of the pneumaticcontrol system 50, a motor 10, and the pneumatic source 32. Theelectronic controller 12 includes an electronic processor 14 and amemory 16.

The electronic processor 14 and the memory 16 can communicate over oneor more control buses, data buses, etc. The electronic processor 14 canbe configured to communicate with the memory 16 to store data andretrieve stored data. The electronic processor 14 can be configured toreceive instructions and data from the memory 16 and execute, amongother things, the instructions. In particular, the electronic processor14 executes instructions stored in and retrieved from the memory 16. Thememory 16 can include read-only memory (ROM), random access memory(RAM), other non-transitory computer-readable media, or a combinationthereof. The memory 16 can include instructions (e.g., software)executable by the electronic processor 14 to enable the electroniccontroller 12 to, among other things, control one or more of thepneumatic source 32, the pneumatic control system 50, and/or the motor10.

For example, the controller 12 may execute software (e.g., theelectronic processor 14 may execute software stored on the memory 16) toregulate the pressure, flow, and temperature of the gas from thepneumatic source 32. This regulation may include receiving sensor datafrom corresponding sensors that indicate one or more of the pressure,flow, and temperature of the gas, and controlling pressure, flow, andtemperature regulating devices (pumps, valves, solenoids, heaters,cooling elements, etc.) based on the sensor data to provide the gas at adesired pressure, flow, and temperature.

Further, the controller 12 may execute software to control the pneumaticcontrol system 50. For example, the pneumatic control system 50 mayinclude at least one controllable inlet valve to control the pressureand/or flow of gas from the pneumatic source 32 to the inlet 36 and atleast one controllable exhaust valve to control the pressure and/or flowof gas from the outlet 38 of the catheter 20 a to an ambient environmentof the system 50 (or other exhaust repository). The controller 12 maydetermine characteristics of the system 100 (e.g., based on sensor datafrom one or more sensors). For example, the pneumatic control system 50can have a plurality of gas flow meters and pressure gauges that can becalibrated to accurately measure and indicate to the controller 12 aflow rate and pressure of gas being delivered to the catheter 20 a(e.g., at the inlet 236). Similarly, the pneumatic control system 50 canhave a plurality of gas flow meters and pressure gauges that can becalibrated to accurately measure and indicate to the controller a flowrate and pressure of the exhausted gas from the catheter 20 a (e.g., atthe outlet 238).

In response to the sensor data provided by the one or more gas flowmeters and pressure gauges, the controller 12 may control the inlet andexhaust vales to control the flow of gas in and out of the catheter 20a. For example, the control signals may be analog voltage signals (e.g.,between 0 and 5 volts), where the voltage indicates the degree to whicha particular valve should be opened (e.g., 2 volts=40% open, 4 volts=80%open, etc.). In some examples, the controller 12 may maintain a desiredflow rate and/or pressure for the gas within the bundle of HFMs 34 bycontrolling the inlet and exhaust valve(s), where, generally, increasingthe degree to which the inlet valve(s) are open will increase thepressure and increase the flow rate; decreasing the degree to which theinlet valve(s) are open will decrease the pressure and decrease the flowrate; increasing the degree to which the exhaust valve(s) are open willdecrease the pressure and increase the flow rate; decreasing the degreeto which the exhaust valve(s) are open the exhaust valve(s) willincrease the pressure and decrease the flow rate. This combination ofinlet and outlet valve control allows the system to operate at similaraverage pressures within the HFMs 34 at varying gas flow rates throughthe fiber. This ability to control both the average pressure and theflow rate can enable the system to maintain a minimum amount of oxygenflowing through the HFMs 34 to constantly deliver fresh oxygen throughthe fiber without significant back diffusion impacts of water vapor intothe HFMs 34.

Thus, the controller 12 and the pneumatic control system 50 can controlthe pressure and flow rate of gas containing oxygen provided to thecatheter 20 a allowing precise titration with continuous monitoring tomatch a patient's needs. In some examples, the controller 12, based onclinician input (e.g., via a user interface in communication with thecontroller 12) can control the pneumatic control system 50 to titrateoxygen pressure and flow through the HFMs 34 in the catheter 20 a tochange oxygen transmission rate as needed by the patient. Thus, thecontroller 12 and the pneumatic control system 50 can be capable ofcontrolling the pressure and flux of oxygen based on the inputs suppliedby a clinician.

Further, the controller 12 may execute software to control the motor 10.In some examples, the motor 10 is a stepper-motor. In other examples,the motor 10 is another type of motor, such as a permanent magnetbrushless DC motor. The motor 10 is coupled to the bundle of HFMs 34such that rotation of the motor 10 causes rotation of the bundle of HFMs34. For example, a rotor of the motor 10 may be coupled to a drive shaft11 that is ultimately coupled to the bundle of HFMs 34. For example, thedrive shaft 11 may be a thin, flexible shaft that extends through thevasculature of the patient with the catheter 20 a. A distal end of thedrive shaft 11 may be coupled to the manifold 42 that is retaining thebundle of HFMs 34. Accordingly, driving the motor 10 to rotate oroscillate, causes the bundle of HFMs 34 to rotate or oscillate.Alternatively, the motor 10 can be magnetically coupled to the bundle ofHFMs 34 via extracorporeal magnets to cause rotation or oscillation ofthe bundle HFMs 34.

As described in further detail below, the controller 12 may control themotor 10 to oscillate (and, thus, the bundle of HFMs 34 to oscillate)according to various oscillation patterns. For example, to implementsome oscillation patterns, the electronic controller 12 drives the motor10 to provide superimposed angular oscillations to the HFMs 34. As alsodescribed further below, the oscillation of the bundle of HFMS 34 causesa diffusive flux of the gas containing oxygen from the bunded HFMs 34into a region of interest of a subject. In particular, the oscillationincreases the diffusive flux of the gas relative to a static(non-rotating) bundle of HFMs and relative to a constantly orunidirectionally rotating bundle of HFMs.

Although the electronic controller 12 is illustrated as a single devicein FIG. 1A (and in FIG. 2A, described below), the electronic controller12 may include one or more controllers each with a respective processor,memory, and/or circuitry to implement the functionality of thecontroller 12 described herein. For example, the electronic controller12 may include a motor controller coupled to the motor 10 and performingthe motor control functions described herein (e.g., driving the motor 10to oscillate the HFMs 34) and a pneumatic controller coupled to thepneumatic control system 50 and performing the pneumatic controlfunctions described herein (e.g., opening and closing valves,controlling flow rate, de-pressurizing the HFMs 34, etc.).

FIG. 1B shows a cross-sectional view of the bundle of HFMs 34 shown inFIG. 1A. The bundle of HFMs 34 is illustrated within catheter shaft 22.The bundle of HFMs 34 is illustrated as included eighteen HFMs, two ofwhich are labeled HFMs 34 a. However, the particular number of HFMswithin the bundle of HFMs 34 may vary. FIG. 1B also illustrates examplesof oscillations resulting from driving of the motor 10, includingmacro-oscillations 120 and micro-oscillations 118. In the exampleembodiment of FIG. 1B, the macro-oscillations 120 are in the range ofapproximately 360°, with α representing an example step of themacro-oscillations 120 of approximately 90°, and β represents themicro-oscillations in the range of approximately 15°. However, themacro-oscillations 120 for the system 100 may be in the range ofapproximately 1-360° (or a narrower range, such as 22.5-360°, 22.5-180°,45-180°, or 90-180°, etc.), with steps α of the macro-oscillation 120being in a range of 1-360° (or a narrower range, such as 22.5-360°,22.5-180°, 45-180°, or 90-180°, etc.), and the micro-oscillations may bein the range of approximately 1-180° (or a narrower range, such as5-45°, 15-30°, 22.5-45°, or 30-90°, etc.). In some examples,macro-oscillations or micro-oscillations of the bundle of HFMs 34, butnot both, are provided in the system 100. Further description of varioustechniques for oscillating the bundle of HFMs 34 is provided below.

Referring now to FIG. 2A, an intravascular oxygenation system 200 isprovided. The system 200 is similar to the system 100, except for thedifferences noted herein, and like parts are described and identifiedwith like names and labels. In the system 200, the bundle of HFMs 34 isprovided in a non-loop arrangement and include a central shaft 228. Forexample, proximal ends of the HFMs 34 and the central shaft 228 may beretained in a proximal end tip 242 of a catheter 20 b, and distal endsof the HFMs 34 and the central shaft 228 may be retained in a distal endtip 244 of the catheter 20 b.

The pneumatic control system 50 is in pneumatic communication with thepneumatic source 32, a pneumatic inlet 236, and pneumatic outlet 238 ofthe catheter 20 b. The catheter 20 b of FIG. 2A and the catheter 20 a ofFIG. 1A-1B, as well as catheters 20 c, 20 d, 20 e, 20 f, and 20 gdescribed below, may generically be referred to as the catheter 20.Accordingly, references to and description of the catheter 20 may applyto each of the catheters 20 a-20 g unless otherwise noted. As describedwith respect to the system 100 of FIG. 1 a , the pneumatic controlsystem 50 can provide regulated gas (e.g., containing oxygen) to theinlet 236. The inlet 236, in turn, may be pneumatically coupled to theproximal end of the central shaft 228 at the proximal end tip 242. Thecentral shaft 228 can extend between the proximal end tip 242 and distalend tip 244. The proximal end tip 242 can retain a proximal end of thecentral shaft 228 and the distal end tip 244 can retain a distal end ofcentral shaft 228 using methods similar to those described for retainingthe HFMs 34 above. For example, in some examples, the proximal ends anddistal ends of HFMs 34 and central shaft 228 can be retained in theproximal end tip 242 and distal end tip 244, respectively, using a highstrength epoxy or other suitable materials for securely potting theproximal and distal ends in the proximal end tip 242 and distal end tip244, respectively.

The central shaft 228 receives gas from the pneumatic inlet 236, whichtravels through the central shaft 228 from the proximal end tip 242 tothe distal end tip 244. The distal end tip 244 can include a pneumaticconnection (or flow path) for the gas that connects the distal end ofthe central shaft 228 to the inlets of the HFMs 34. Accordingly, thecentral shaft 228 can provide the gas, received via inlet 236, to inletsof the HFMs 34 at the distal end tip 244. The outlets of the HFMs 34 arein pneumatic communication with the pneumatic outlet 238. For example,the proximal end tip 242 can include a pneumatic connection (or flowpath) for gas that connects the proximal end of the HFMs 34 to thepneumatic outlet 238. Accordingly, the HFMs 34 can provide gas, receivedfrom the central shaft 228 at the distal end tip 244, to the pneumaticoutlet 238 at the proximal end tip 242. Thus, in these examples, thecentral shaft 228 provides a forward path for the gas from the proximalend tip 242 to the distal end tip 244, and the HFMs 34 define a returnpath for a gas from the distal end tip 244 to the proximal end tip 242.

In some embodiments of the system 200, the inlet 236 is coupled to theproximal ends of the HFMs 34 at the proximal end tip 242 and outlet 238is coupled to the proximal end of the central shaft 228 at the proximalend tip 242, thereby causing the flow path of the gas to be reversed.More particularly, the gas from the pneumatic control system 50 may beprovided to the inlet 236, may flow into the HFMs 34 at the proximal endtip 242, may flow out of the HFMs 34 at the distal end tip 244 and enterinto the distal end of the central shaft 228, may flow through thecentral shaft 228 and into the outlet 238 at the proximal end tip 242.

In the context of the oxygenation systems described herein, the gastransiting the inlets 36 or 236 and entering into the HFMs 34 may bereferred to as oxygenated gas, and the gas exiting the HFMs 34 andtransiting the outlets 38 or 238 may be referred to as deoxygenated gas.The deoxygenated gas may still have oxygen present, but because of thediffusion occurring via the HFMs 34, the deoxygenated gas exiting theHFMs 34 will have a lower level of oxygen than the oxygenated gasentering the HFMs 34.

The bundle of HFMs 34 can have a looped configuration (see FIG. 1A) or anon-looped configuration (see FIG. 2A), and HFMs 34 can further beprovided in a number of arrangements including a bulb shape, a twist, ahelix, a braid pattern, and others. For example, FIG. 1A shows aschematic illustration of the HFMs 34 in a looped configuration with afanned arrangement in which the HFMs 34 spread out past the distal end26 of the catheter shaft 22 and extend to a distal end 44 of the HFMs34. In contrast, FIG. 2A shows a schematic illustration of the HFMs in anon-looped configuration extending between the proximal end tip 242 andthe distal end tip 244 in a bulging arrangement. In some examples, thesystems 100 and 200 may employ a bundle of HFMs 34 having a differentconfiguration and/or arrangement than shown in FIGS. 1A and 2A, such asthose described herein. The HFMs 34 may be configured to optimizenon-laminar blood flow exposure to the HFMs 34 in terms of length, innerand outer diameter of HFMs 34, number of HFMs 34, outer diameter of theHFMs 34 bundle, and positioning of HFMs 34.

The pressure under which the gas containing oxygen flows is well underthe bursting pressure of the HFMs 34 to ensure safety, and the gasflowing through the HFMs 34 is temperature and flow controlled asdescribed above. In some examples, the pneumatic control system 50includes safety shut-off valves that detect a drop in pressure and willinstantly stop gas flow through the central shaft 228 or HFMs 34 if aleak were to develop, thereby preventing venous gas emboli formation. Insome examples, the pneumatic control system can have three (3) channelsthat provide high pressure oxygen to the central shaft 228 or HFMs 34.The HFMs 34 can be separately grouped or “banked” into three (3) groupsthat can be individually monitored for pressure through each group viathe three (3) channels. If there is a sudden drop in pressure, as therewould be in a catastrophic failure of one or more of the HFMs 34 or thecentral shaft 228, the pneumatic control system 50 will sense thefailure and instantly shut off gas flow through that channel (andtherefore bank of HFMs 34) to prevent gas emboli (blowing gas directlyinto blood stream from failed hollow fiber). It is to be appreciatedthat the number of groups and channels described above are exemplary andany appropriate number of groups and channels can be utilized.

In some examples, the pneumatic control system 50 further includes avacuum system 237 (see FIG. 2A) to selectively de-pressurize the HFMs34, e.g., in the case of a detected fault or sudden drop in pressure inthe HFMs 34. For example, the vacuum system 237 may include a pump thatis pneumatically connected to the HFMs 34 (e.g., via the inlet 236)selectively (e.g., via a controllable valve). In the case of theelectronic controller 12 detecting a fault or sudden drop in pressure,the electronic controller 12 may selectively control the controllablevalve to connect the pump of the vacuum system 237 to the HFMs 34,control inlet valve(s) connected to the pneumatic source 32 and outletvalves connected to the outlet 38 to close, and enable the pump tode-pressurize the HFMs 34. The vacuum system 237 may also be present inthe pneumatic control system 50 of the system 100 of FIG. 1A. To detecta sudden drop in pressure, in some examples, the electronic controller12 may receive sensor data (e.g., from a pressure sensor of thepneumatic control system 50) indicative of the pressure of the HFMs 34and/or the rate of change of pressure of the HFMs 34. The electroniccontroller 12 may compare the indicated rate of change of pressure to asudden drop rate threshold and a total change in pressure for theassociated time period (determined from the pressure data) to a suddendrop change threshold. The electronic controller 12 may, in response todetermining that these thresholds are exceeded, determine that a suddendrop in pressure has occurred and de-pressurize the HFMs 34.Accordingly, the electronic controller is configured to control thevacuum system to de-pressurize the HFMs 34 in response to determining aloss of pressure in the HFMs exceeding a threshold (e.g., the suddendrop change threshold and/or the sudden drop rate threshold).

Hollow Fiber Membranes (HFMs)

The HFMs 34 of the various systems provided herein, including systems100 and 200, receive high pressure gas containing oxygen from pneumaticcontrol system 50. The gas containing oxygen flows through the HFMs 34to provide diffusive flux of oxygen through the walls of the HFMs 34. Inembodiments provided herein, the diffusive flux of the gas containingoxygen can have an operating range at or above 500 mL per minute persquare meter.

The HFMs 34 may have small radii and, accordingly, can withstand highinternal pressures according to LaPlace's Law since:

Wall Tension=(P)(R)

where P is pressure and R is the radius. The ability to safely withstandhigh pressure means that significant flux can be achieved with only amodest surface area.

The HFMs 34 are solid wall nonporous membranes configured to deliveroxygen using exclusively diffusion rather than convection through aporous surface. Diffusion through a porous surface risks formation ofhigh volume and large diameter bubbles, which can be undesirable for apatient, especially at hyperbaric pressures. The high-pressure gascontaining oxygen, which in some aspects may be hyperbaric, flowingthrough the HFMs 34 creates a driving gradient, based on Fick's laws ofdiffusion. The driving gradient diffuses oxygen out of an interiorchamber of the HFMs 34 as it dissolves through the nonporous membrane ofthe HFMs 34 to an exterior side of the nonporous membrane and into, forexample, blood flowing past the HFMs 34 in the region of interest of thesubject. Generally, with a bundle of the plurality of HFMs 34, fluidflowing past can flow between the individual HFMs 34 to expose anincreased surface area of HFMs 34 to fluid flowing past. In someaspects, a high partial pressure of oxygen generates the pressuregradient that greatly increases oxygen transmission from the HFMs 34 toa region of interest of the subject. The pressure gradient generated bythe hyperbaric oxygen concentration in the HFMs 34 allows for areduction in size of the catheter shaft 22 since it is not relying on anextraordinarily large surface area to generate diffusivity. As discussedin detail below, the hyperbaric nature of the catheter 20 providesimproved intravascular oxygenation via the pressure gradient between theHFMs 34 and a region of interest. The catheter 20 can be adjusted asneeded for the subject's size and can be sized to be used in a range ofsubjects, including, but not limited to neonatal, pediatric, and adultpatients.

Catheter Sizing and Insertion

In the systems described herein, including the systems 100 and 200, thecatheter 20 may include a portion of inlet and outlet tubing (e.g.,inlet 36, 236 and outlet 38, 238), one or more sheathing elements, abundle of HFMs 34, and one or more associated bundle elements (e.g., aguard (described below), a central axis (e.g., central shaft 228), anHFM support (described below), a pump (described below), and/or otheraspects of the systems inserted into a subject). The catheter 20 thatprovides intravascular oxygenation to the subject has a reduced size dueto the reliance on a large oxygen concentration gradient drivingdiffusion rather than convection through a porous wall. The reduced sizeof the catheter 20 dimensioned for insertion into a region of interest,improves biocompatibility due to reduced surface area in contact withthe blood, and minimizes any hemodynamic effect. In some non-limitingaspects, the catheter shaft 22 can have a diameter of two (2)millimeters (mm) or six (6) French (Fr). In still other non-limitingaspects, the catheter shaft 22 (FIG. 1A) and the catheter shaft 222(FIG. 2A) can have a diameter between one (1) mm and three (3) mm, or 3Fr and 9 Fr. The diameters of the catheter 20 can be betweenapproximately 1 mm to 16 mm. As explained in further detail below, insome examples, the catheter 20 can have a traveling or compressed statewhere the bundle of HFMs 34 are compacted together for the insertion andplacement of the catheter 20 within a subject, and a deployed statewhere the HFMs 34 are expanded out for operation of the oxygenationsystem. In such examples, the catheter 20 may have a diameter of between1 to 12 mm (3 and 36 Fr respectively) in the compressed state, and alarger diameter in the deployed state than in the compressed state. Forexample, the catheter may expand up to a diameter of 25 mm in thedeployed state.

The catheter 20 is scalable such that it could be a small sizeappropriate for use in a neonate all the way up to a size appropriatefor an adult. As such, it could range in size from one loop of HFM 34,to dozens of HFMs 34, to above 100 HFMs 34. For example, the number ofHFMs 34 in the bundle of HFMs 34 can be in a range of between 1-400HFMs, between 1-100 HFMs,between 100 and 200 HFMs, between 100 and 300HFMs, between 200 and 300 HFMs, between 200 and 400 HFMs, between 300and 400 HFMs, between 250 and 350 HFMs, etc.). In a non-limiting aspect,the catheter 20 of FIG. 1B may have nineteen (19) hollow fiber membranes34 retained in the manifold 42 of the catheter shaft 22. In anothernon-limiting aspect, any appropriate number of HFMs 34 can be positionedin the catheter 20, for example between 1-400 HFMs, between 1-100 HFMs,between 100 and 200 HFMs, between 100 and 300 HFMs, between 200 and 300HFMs, between 200 and 400 HFMs, between 300 and 400 HFMs, between 250and 350 HFMs, etc., etc. can be located in the catheter 20.

In a non-limiting aspect, each individual HFM 34 can be 254 micrometers(μm) in diameter and have a wall thickness 25.4 μm. In a non-limitingaspect, each individual HFM 34 can be between 200 and 800 micrometers(μm), including but not limited to, between 250 and 750 micrometers(μm), between 300 and 500 micrometers (μm), or between 350 and 450micrometers (μm) in diameter and have a wall thickness between 20 and 30μm. In another non-limiting aspect, HFMs 34 can be 406.4 micrometers(μm) in diameter with a wall thickness of 88.9 micrometers (μm). In anon-limiting aspect, each individual HFM 35 can have a wall thickness ofbetween 10 and 500 micrometers (μm), including but not limited to,between 25 and 400 micrometers (μm), between 50 and 250 micrometers(μm), or between 75 and 125 micrometers (μm). In other non-limitingaspect, the HFMs 34 can range from 200 micrometers (μm) to 1800micrometers (μm) in diameter with wall thicknesses ranging from 25micrometers (μm) to 300 micrometers (μm). Additionally, the HFMs 34 canbe custom manufactured to have varying wall thickness. In somenon-limiting aspects, the HFMs 34 can extend to a length of 10 cm or 30cm in a direction parallel with the longitudinal axis 28 of the catheter20. In some non-limiting aspects, the HFMs 34 can extend to a lengthbetween 5 cm and 20 cm or between 5 cm and 50 cm in a direction parallelwith the longitudinal axis 28 of the catheter 20.

Additionally, in some examples, a total surface area of the HFMs 34 maybe between 0.02 m² to 0.20 m², or a sub-range therein, such as 0.05 m²to 0.15 m², 0.07 m² to 0.13 m², 0.09 m² to 0.11 m², or the like.

Accordingly, because of the increased oxygen diffusion flux provided bythe catheters 20 in the systems and methods described herein, the bundleof HFMs 34 of the various examples of catheters 20 provided herein maybe substantially more compact, e.g., in terms of quantity of HFMs 34(e.g., 33% , 50%, or more reduction) and in terms of surface area of theHFMs 34 (e.g., 66%, 83%, or more reduction), than other known systems,while still achieving desired oxygen transfer rates to a subject. Insome examples, an oxygen transfer rate to a subject may be at or around50 ml O₂/minute, although the particular rate may change depending oncircumstances of a subject.

The catheter 20 may be flexible such that it can be insertednon-invasively to a region of interest in a subject. The catheter 20 isdimensioned for intravascular placement into a subject at bedside via apercutaneous approach to reach the region of interest. The catheter 20is dimensioned for placement into the region of interest using anintroducer sheath that can provide guidance for the catheter 20 to reachthe region of interest. In a non-limiting example, the region ofinterest may be a large vessel such as the inferior vena cava, or thecatheter 20 could be placed across the right atrium of the subject'sheart. The catheter 20 can be placed peripherally (e.g. into the groinor neck) and maneuvered to a central venous location such as theinferior or superior vena cava or into the right atrium. The catheter 20can also be positioned in the arterial side in select patients so thatthe catheter 20 could be positioned in the aorta. Additionally, thecatheter 20 could be positioned in other regions of interest other thanthe vasculature such as intrathecal, intraperitoneal, or subcutaneously.As will be discussed in more detail below, catheter 20 may bemanufactured from biocompatible material(s) and can be disposable. Insome aspects, the catheter 20 can be placed surgically, for example, inthe inferior or superior vena cava. The hyperbaric nature of thecatheter 20 provides improved intravascular oxygenation via the pressuregradient between the HFMs 34 and the region(s) of interest discussedabove.

As discussed above, the catheter 20 can be used for intravascularoxygenation of a region of interest in a subject by oxygenating theblood in a patient, which may be a critically ill patient with sick andfailing lungs. The catheter 20 is dimensioned for insertionintravascularly and diffuses oxygen into the blood that flows past itdue to the hyperbaric nature of the catheter 20 and oscillation of theHFMs 34, offloading much of the work of the patient's lungs andsupporting the patient as the lungs heal from the underlying disease.The catheter 20 can maintain adequate oxygenation in patients with bothacute and chronic lung diseases and can be an adjunct to mechanicalventilation (or could be used by itself) and may replace or delay theneed for Extracorporeal Membrane Oxygenation. The Intravascular MembraneOxygenator Catheter overcomes these limitations through a design that iseasy to deploy, simple to use, and delivers a clinically significantamount of oxygen to the patient. In some aspects, the catheter 20 candeliver any amount of oxygen that could be useful to the patient.Accordingly, the catheter 20 may deliver at least 0.1 percent of thepatient's oxygen needs. The catheter 20 may deliver between 0.1 percentand one percent of the patient's oxygen needs. In some aspects, thecatheter 20 may deliver greater than one (1) percent of the patient'soxygen needs. For example, the catheter 20 may deliver one (1) percentto five (5) percent of the patient's oxygen needs. In some aspects, thecatheter 20 may deliver five (5) percent to twenty-five (25) percent ofthe patient's oxygen needs. In some aspects, the catheter 20 may delivertwenty five (25) percent or more of a patient's basal oxygen needs in acatheter 20 configured to be sized to easily fit intravascularly into aregion of interest. Furthermore, the catheter may deliver 50-100% of thepatient's basal oxygen demand. In some cases, the catheter may delivergreater than 100% of the patient's basal oxygen demand.

Using known oxygen permeabilities and tensile strengths of variousmaterials (e.g. polymers), a small bundle of HFMs 34, which may be equalor smaller in size than current central intravenous catheters,oscillated and placed under high pressures (for example, at or above 1.1bar of absolute pressure, between 1.1 bar and 2 bar, or between 1.1 barand 5 bar of absolute pressure) can diffuse a clinically significantamount of oxygen at well under the bursting pressures of the HFMs 34. Insome examples, oxygenated gas is provided to the HFMs 34 at a pressureabove or below the 1.1 bar to 2 bar range.

The catheter 20 (and HFMs 34) may include a traveling state withcompressed HFMs 34 and a deployed state with deployed or expanded HFMs34. For example, referring again to FIG. 2A, the catheter 20 b caninclude a retractable sheath 235 that can compress the HFMs 34 duringinsertion and travelling to a region of interest. When the retractablesheath 235 surrounds and compresses the HFMs 34, the catheter 20 b (andHFMs 34) is in a travelling state. During deployment, the retractablesheath 235 can be retracted in a proximal direction (away from a distalend of the HFMs 34) along the catheter shaft 222 to deploy the HFMs 34.In some embodiments, an expandable spacer 240 can be provided with theHFMs 34 and used to deploy the HFMs 34. For example, the expandablespacer 240 may be a spring that is compressed by the retractable sheath235 when the catheter 20 b is in the traveling state, and that expandsdue to the spring forces when the retractable sheath 235 is retracted.The expandable spacer 240 may further be coupled to one or more HFMs 34to cause the expansion of the HFMs 34 as the spacer 240 expands.

Referring now to FIG. 2B, a catheter 20 c is illustrated. The catheter20 c is similar to the catheter 20 b of FIG. 2A in that the catheter 20c includes HFMs 34 in a non-looped arrangement and a central shaft 228coupled between a proximal end tip 242 and a distal end tip 244. Thecatheter shaft 222 may, similar to FIG. 2A, include a drive shaft 11coupled to a motor 10, and an inlet 236 and outlet 238 coupled to apneumatic control system 50, and each may be configured and function asdescribed above with respect to FIG. 2A. Thus, the catheter 20 c of FIG.2B may be used in the system 200 of FIG. 2A in place of the catheter 20b and/or in the system 100 of FIG. 1A in place of the catheter 20 a. Inthe illustration of FIG. 2B, the proximal and distal end tips 242 and244 retaining and providing pneumatic connections for the HFMs 34 andcentral shaft 228 are more pronounced. Such end tips may also be presentin the catheter 20 b of FIG. 2A. Although not shown in FIG. 2B, thecatheter 20 c may also be provided with a retractable sheath 235 such asdescribed with respect to the catheter 20 b, which may similarly definea traveling state and deployed state for the catheter 20 c.

The catheter 20 c of FIG. 2B further includes a protective guard 280.The protective guard 280 also extends between (and has ends retained by)the proximal end tip 242 and the distal end tip 244. The protectiveguard may be, for example, a wire mesh cage, a self-expanding stentcomprising nitinol, a semipermeable sheath, or a balloon-expandablestent. The protective guard 280 may surround or contain the HFMs 34. Insome examples, proximal end tip 242 and the distal end tip 244 may eachinclude a static portion and a rotatable portion that may rotaterelative to one another. For example, the portions may be coupled by abushing to enable the relative rotation. The protective guard 280 may becoupled to and retained by the static portion, while the drive shaft 11and the HFMs 34 may be coupled to and retained by the rotatable portion.Accordingly, the protective guard 280 and static portion of the end tips242 and 244 may remain stationary while the HFMs 34 and rotatableportions of the end tips 242 and 244 are rotated or oscillated by themotor 10 via drive shaft 11 (e.g., as indicate by oscillations 265).

In some alternate examples, the protective guard would be part of aseparate stent that is inserted into a region of interest (avasculature) of a subject first, and then catheter 20 with HFM bundle 34are inserted into the protective guard. The bundle of HFMs 34 may thenbe deployed (expanded), if inserted in a compressed state, and thenoscillated according to the various techniques described herein.Accordingly, in these embodiments, the protective guard may not bephysically coupled to the HFM bundle 34 within the region of interest.In some examples, having the protective guard inserted separately fromthe bundle of HFMs 34 provides a reduced insertional size for theoxygenation system.

FIG. 2C shows a cross-sectional view of the catheter 20 c shown in FIG.2B. The bundle of HFMs 34 is illustrated within protective guard 280 ina (compressed) traveling state, although the retractable sheath 235providing the compression is not illustrated. The bundle of HFMs 34 isillustrated as included eighteen HFMs, two of which are labeled HFMs 34a. The central shaft 228 is also illustrated within the catheter shaft222. However, the particular number of HFMs within the bundle of HFMs 34may vary (e.g., between 100 and 200 HFMs, between 100 and 300 HFMs,between 200 and 300 HFMs, etc., as described above). FIG. 2C alsoillustrates examples of oscillations resulting from driving of the motor10, including macro-oscillations 220 and micro-oscillations 218. In theexample embodiment of FIG. 1B, the macro-oscillations 220 are in therange of approximately 360°, with α representing an example step of themacro-oscillations 120 of approximately 90 degrees, and β represents themicro-oscillations in the range of approximately 15°. However, themacro-oscillations 120 for the system 100 may be in the range ofapproximately 1-360° (or a narrower range, such as 22.5-360°, 22.5-180°,45-180°, or 90-180°, etc.), with steps a of the macro-oscillation 120being in a range of 1-360 (or a narrower range, such as 22.5-360°,22.5-180°, 45-180°, or 90-180°, etc.), and the micro-oscillations may bein the range of approximately 1-180° (or a narrower range, such as5-45°, 15-30°, 22.5-45°, 30-90°). In some examples, macro-oscillationsor micro-oscillations of the bundle of HFMs 34, but not both, areprovided in the system 200. Further description of various techniquesfor oscillating the bundle of HFMs 34 is provided below.

In some examples, in place of or in addition to a retractable sheath,such as the retractable sheath 235, the HFMs 34 may be wound around acentral shaft, such as the central shaft 228, to place the catheter 20in compressed state. For example, to wind the HFMs 34, the distal end244 may be rotated in a first direction while the proximal end 242 isstationary. Then, to place the catheter 20 in the deployed state, theHFMs 34 may be unwound. For example, to unwind the HFMs 34, the distalend 244 may be rotated in a second direction (opposite the firstdirection). The unwinding force may be provided by conversion ofpotential energy stored in the wound HFMs 34 (e.g., serving as a spring)to kinetic energy. In some examples, the retractable sheath 235maintains the HFMs 34 in a wound state, and retracting of theretractable sheath 235 may cause the HFMs 34 to unwind to the deployedstate.

Referring now to FIG. 3A, a compressed travelling state conformation ofthe HFMs 34 (without guard 280) of the catheter 20 c is shown. In someembodiments, the HFMs are compressed by a retractable sheath 235 (notshown), which defines a travelling state conformation. Referring now toFIG. 3B, a deployed state conformation of the HFMs 34 (with guard 280)of the catheter 20 c is shown. Retracting the retractable sheath 235 canrelease the HFMs 34 and define the deployed state. In some examples, aprotective guard 280 surrounds the HFMs 34 in the travelling stateconformation, the deployed state conformation, or both conformations.

FIGS. 4A-4B illustrate a magnified view of a distal end of the catheter20 c of FIG. 2B in a traveling (compressed) state and a deployed(expanded) state, respectively. Referring now to FIG. 4A, the HFMs 34are in the traveling state, and only a portion of the length of the HFMs34 are illustrated (rather than the full length of the HFMs 34). Asdescribed above, the HFMs 34 and central shaft 228 can be retained bythe distal end tip 244. Referring now to FIG. 4B, the HFMs 34 are in adeployed state and only a portion of the length of the HFMs 34 areillustrated (rather than the full length of the HFMs 34). In operation,the gas containing oxygen (also referred to as oxygenated gas),identified as gas 415 in FIG. 4B, may travel through the central shaft228 to the distal end tip 244 and be exhausted from the central shaft228 into the distal end tip 244. The oxygenated gas 415 can then bereceived by inlets 414 of each of the HFMs 34 through an air channel orvolume 416 defined by the distal end tip 244. The oxygenated gas 415then travels in a proximal direction (towards the proximal end tip 242,see FIG. 2C) from the distal end tip 244 through the HFMs 34. In someembodiments, the inlets 414 are configured to receive the gas in thedistal end tip 244 through a vacuum created by a pneumatic controlsystem, thereby pulling the gas through the inlets 414 of the HFMs 34.

FIG. 5 illustrates another magnified view of the distal end of thecatheter 20 c of FIG. 2B, similar to FIG. 4B, except that the protectiveguard 280 is also illustrated.

FIG. 6 illustrates a magnified view of a distal end of a catheter 20 d,which is another embodiment of the catheter 20. The catheter 20 d may besimilar to the catheter 20 c, except for any differences noted herein.The catheter 20 d that includes an independent rotational device 620(e.g., a miniaturized motor or oscillator) connected to the centralshaft 228. The independent rotational device 620 can oscillate the HFMs34 to. This device 620 may also be capable of compressing to fit insideof the bundled HFMs in the compressed state configuration prior todeployment. In some embodiments, the oxygenation system 100 or 200includes the catheter 20 d with independent rotation device 620 in placeof the motor 10 and drive shaft 11 to oscillate the HFMs 34.

FIG. 7A illustrates a magnified view of a proximal end of the catheter20 c of FIG. 2B. In this view, a double lumen 700 of a proximal section702 of the central shaft 228 is shown. The proximal section 702 of thecentral shaft 228 can be understood to include the portion of thecentral shaft 228 that is disposed within the proximal end tip 242 ofthe oxygenation system 200 and that connects to the pneumatic inlet 236and pneumatic outlet 238. The double lumen 700 of the central shaft 228includes an inflow lumen 710 pneumatically coupled to the pneumaticinlet 236 and extending through the central shaft to the distal end tip244 to pneumatically couple to the HFMs 34 (see, e.g., FIG. 5 ). Thedouble lumen 700 further includes an outflow lumen 720 pneumaticallycoupled to the distal ends of the HFMs 34 at the proximal end tip 242.For example, the outlets (or distal ends) 714 of the HFM 34 may exhaustdeoxygenated gas 715 into an air channel or volume 716 defined by theproximal end tip 242. The deoxygenated gas 715 may then be received theoutflow lumen 720. Accordingly, the inflow lumen 710 is configured toreceive a high-pressure gas 415 containing oxygen from the pneumaticinlet 236 and transport the gas 415 to inlets of the HFMs 34 at thedistal end tip 244. The outflow lumen 820 is configured to receivedeoxygenated gas 715 from the outlets of the HFMs 34 at the proximal endtip 242 and transport the deoxygenated gas 715 to the pneumatic outlet238.

FIG. 7B illustrates a schematic diagram of the double lumen 700 of theproximal section 702 of the central shaft 228. As described with respectto FIG. 7A, the inflow lumen 710 can extend the entire length of thecentral shaft 228 defined between the proximal end tip 242 and distalend tip 244. The outflow lumen 720 can extend alongside the inflow lumenalong a length confined within the proximal end tip 242. However, theoutflow lumen 720 can also extend the entire length of the central shaft228 in certain aspects. The outflow lumen 720 can be connected to eachoutlet of the HFMs 34, or the outflow lumen 720 can be connected to afluid channel disposed within the proximal end tip 242 that places theoutflow lumen 720 in fluid communication with the outlets of the HFMs.For example, the outflow lumen may include one or more openings 724 (seeFIG. 7A) in fluid communication with the volume 716 of the proximal endtip 242 (see FIG. 7B) to receive the outflow of deoxygenated gas 715from the outlets of the HFMs 34.

As noted above, in some examples, the catheter 20 c is designed suchthat the flow path of the gas is reversed, in which case the lumen 720may be an inlet that provides an inflow of gas received from thepneumatic inlet 236 to the proximal end of the HFMs 34, and the lumen710 may be an outlet that receives an exhaust of deoxygenated gas fromthe distal ends of the HFMs 34 and transports the deoxygenated gas alongthe length of the central shaft 228 back to the pneumatic outlet 238.

FIG. 7C illustrates a magnified view of a proximal end of a catheter 20e. The catheter 20 e may also be used in some examples of the system200. The catheter 20 e may be similar to the catheter 20 c except forthe differences noted herein. In particular, instead of having an inflowlumen and an outflow lumen coupled to the inlet 236 and outlet 238,respectively, the catheter 20 e has one shared lumen 700 a coupled toboth the inlet 236 and the outlet 238 that serves as both inlet andoutlet to the HFMs 34 in a time-multiplexed fashion. In particular, alumen 700 a of the central shaft 228 is connected to both the outlet 238and inlet 236. The lumen 700 a may be pneumatically coupled to the HFMs34 either at the proximal end tip 242 shown in FIG. 7C, or at a distalend tip of the catheter 20 e (see, distal end tip 244 of FIG. 5 ). Inoperation, the system 200 (e.g., the pneumatic control system 50 undercontrol by the electronic processor 12) performs a cyclic process offilling and draining the HFMs 34 with oxygenated gas through the sharedlumen 700 a. For example, the system 200 fills the HFMs 34 withoxygenated gas under pressure through the shared lumen 700 a (serving asan inlet) and holds the gas at the pressure for a set amount of time.Then, the system 200 generates a vacuum (e.g., using vacuum system 237)to pull out the oxygenated gas (and back-diffused water vapor) from theHFMs 34 through the shared lumen 700 a (now acting as an outlet). Thesystem 200 then restarts the cyclic process to continually fill, hold,and pull oxygenated gas in the HFMs 34. With a shared orifice and lumen,the catheter 20 e may have a less complex construction than othercatheters 20 having distinct inlet and outlets.

FIG. 8 illustrates a flowchart of a process 800 for intravascularoxygenation, which can be implemented using any of the systems describedherein. For example, the process 800 may be implemented with the system100, the system 200, any of catheters 20 (e.g., catheters 20 a, 20 b, 20c, or 20 d), as well as by variations of these systems and other systemshaving additional components, fewer components, alternative components,or the like. Additionally, although the blocks of the process 800 areillustrated in a particular order, in some embodiments, one or more ofthe blocks can be executed partially or entirely in parallel, can beexecuted in a different order than illustrated in FIG. 8 , or can bebypassed. For illustration purposes, the process 800 is generallydescribed as being implemented by the oxygenation system 200 withcatheter 20 c (see, e.g., FIGS. 2A-5, 7A, and 7B).

In block 805, a pneumatic inlet coupled to a pneumatic source receives agas containing oxygen at a pressure at or above 1.1 bar of absolutepressure. For example, with reference to FIG. 2A, the pneumatic inlet236 may receive a gas containing oxygen (also referred to as oxygenatedgas) 415 from the pneumatic source 32 via pneumatic control system 50.In some examples, as described above, the electronic controller 12 maycontrol the pneumatic source 32 and/or the pneumatic control system 50to provide the oxygenated gas 415 (and regulate the oxygenated gas 415to be at) a particular pressure (e.g., at or above 1.1 bar of absolutepressure), a particular temperature, and/or a particular flow rate. Forexample, the particular pressure, temperature, and/or flow rate of theoxygenated gas 415 may be based on clinician input received by theelectronic controller 12 via a user interface thereof (e.g., a touchscreen, dials, knobs, etc.). That is, the clinician input may includetarget pressure, temperature, and/or flow rate of the oxygenated gas415, and the electronic controller 12 may then regulate the targetpressure, temperature, and/or flow rate of the oxygenated gas 415 to beprovided at the target pressure, temperature, and/or flow rate (withincertain acceptable tolerances). The electronic controller 12 mayregulate these characteristics of the oxygenated gas 415 via control ofone or more valves (to control pressure and flow rate) and one or moreheating or cooling devices (to control temperature) of the pneumaticcontrol system 50 and/or pneumatic source 32. This control may be basedon one or more sensor outputs received by the electronic controller 12indicating one or more of the pressure, temperature, and flow rate at,for example, the inlet 236 and outlet 238.

In block 810, a plurality of hollow fiber membranes (HFMs) in pneumaticcommunication with the pneumatic inlet receive the gas containingoxygen. For example, the bundle of HFMs 34 may be in communication withthe pneumatic inlet 236 and receive the oxygenated gas 415 from thepneumatic inlet 236. For example, with reference to FIG. 7A, thepneumatic inlet 36 may be coupled to the inflow lumen 710 of the doublelumen 800 of the central shaft 228. With reference to FIG. 4B, theinflow of the oxygenated gas 415 may be transported by the central shaft228 (through the inflow lumen 710) to the distal tip end 244. Theoxygenated gas 415 may then be received by the inlets 414 of the HFMs34, as described with respect to FIG. 4B. In other examples, the flowmay be reversed, and the inlet 236 is pneumatically coupled to distalends of the HFMs 34 at the distal end tip 244 to receive the oxygenatedgas 415.

In block 815, an electronic controller drives a motor to oscillate theplurality of HFMs to cause a diffusive flux of the gas containing oxygenfrom an interior of the plurality of HFMs in a region of interest of asubject. For example, the electronic controller 12 may drive the motor10 to oscillate the HFMs 34 according to one or more oscillationpatterns. Oscillation patterns may include macro-oscillations,micro-oscillations, or a combination of macro-and micro-oscillations.Examples of oscillation patterns are discussed further below. Theoscillation may be one cause of a plurality of causes for the diffusiveflux of the gas (e.g., the construction of the HFMs, the hyperbaricpressure of the gas containing oxygen in the HFMs, etc.). Accordingly,in some examples, the diffusive flux referred to in block 815 may beconsidered the total diffusive flux resulting from the overall systemand its operation (as the oscillations contribute to causing thisoverall diffusive flux), or may be considered the increase in diffusiveflux attributable to the oscillation of the HFMs 34.

The oscillation of the HFMs 34 ultimately increases the diffusive fluxof the gas into the region of interest from the HFMs 34, relative tostatic HFMs 34 or unidirectionally or constantly rotating HFMs 34. Forexample, oscillation causing the movement of HFMs in a directionperpendicular to blood flow can create a higher effective shear flowthat reduces the opportunity for bubble formation. Additionally,oscillating the HFMs can increase convective mixing of the blood andincrease the relative velocity of blood flowing past the HFM, which canreduce liquid boundary layer formation. These mechanisms both serve toreduce bubble formation and increase oxygen flux. Also, oscillations caninduce movement such that the HFMs may have less opportunity forfiber-to-fiber contact in the vascular path, which could otherwisereduce efficiency. Further, the oscillations may induce vibrations alongthe fiber, and/or the motion of the oscillator can also directly orindirectly create a longitudinal wave along the length of the HFM,either or both of which may dislodge microscopic bubbles before theygrow in size, increase convective mixing and reduce liquid boundarylayer formation.

Additionally, with the increase in diffusive flux provided by theoscillations, the pressure of the oxygenated and deoxygenated gas in thecatheter 20 and HFMs 34 may be reduced, relative to a system attemptingto achieve similar diffusive flux rates that does not includeoscillations. Moreover, the pressures required in a non-oscillatingsystem to achieve similar diffusive flux may be too high and outside ofan acceptable operation range of the HFMs or system. In other words, theoscillation of the HFMs 34 enables the system 200 (and 100) to achievediffusive flux and higher rates than possible with non-oscillating(static or unidirectionally or constantly rotating) HFMs.

To oscillate the HFMs 34, the motor 10 may be coupled via a drive shaft11 to the HFMs 34, as described above (e.g., with respect to FIGS.2A-2B). Further, the electronic controller 12 may be programmed with oneor more oscillation profiles, each profile associated with anoscillation pattern. Each oscillation profile may encode the oscillationpattern for the motor 10 to implement. Accordingly, the profile mayinclude one or more of rotation angles (indicating an amount of rotationfor an oscillation), angular positions (about which oscillations are tooccur), rotation speeds (for a particular oscillation and/or fortransiting between angular positions), and the like to define themovements of the motor 10 that make up an oscillation pattern. In someexamples, one or more of these angles, positions, and speeds of one ormore of the oscillation profiles may be pre-configured (e.g., at thetime of manufacture or firmware update). In some examples, one or moreof these angles, positions, and speeds of one or more of the oscillationprofiles may be configurable, for example, by a clinician. For example,the oscillation profiles may be stored in the memory 16 of theelectronic controller 12 and associated with an identifier (e.g., aname). A particular oscillation profile may be selected and/orconfigured based on clinician input received by a user interface of theelectronic controller 12. In some examples, the clinician input includesa selection of a particular oscillation profile and/or configurationinformation indicative of the angles, positions, or speeds to be usedfor the profile. In other examples, the clinician input includes desiredoxygenation characteristics. The electronic controller 12 may, in turn,select an oscillation profile and/or configuration of an oscillationprofile associated with such oxygenation characteristics. Accordingly,based on a clinician input requesting an increase in the oxygenation ofa region of interest, the electronic controller 12 may select a newoscillation profile and configuration, and/or modify a configuration ofa current oscillation profile, that results in an increase inoxygenation (i.e., an increase in the diffusion flux). Similarly, basedon a clinician input requesting a decrease in the oxygenation of aregion of interest, the electronic controller 12 may select a newoscillation profile and configuration, and/or modify a configuration ofa current oscillation profile, that results in a decrease in oxygenation(i.e., a decrease in the diffusion flux). In some examples, eachoscillation profile may be associated with an oxygenation capability(e.g., defined as a ranking or score (e.g., 1-10) or with an average,maximum, and/or minimum oxygenation rate), a risk of hemolysis (orbubble formation) (e.g., defined as a ranking or score (e.g., 1-10) oranother metric), and/or other characteristics. Accordingly, someoscillation profiles may be associated with higher oxygenation levels,but also with an increased risk of hemolysis (or bubbles), relative toother oscillation profiles. Nevertheless, in certain scenarios, aclinician may select such an oscillation profile, at least temporarily,taking into consideration the risk/benefit of treatment and theparticular situation of a subject.

Accordingly, the electronic controller 12 may select and retrieve theoscillation profile (e.g., based on clinician input, pre-configuration,or otherwise). The electronic controller 12 may then translate theoscillation profile to motor drive commands (e.g., a series of commandsto rotate the motor 10 clockwise and counterclockwise particular amountsand at particular speeds) and provide the motor drive commands to themotor 10 to achieve the oscillation pattern associated with the profile.In other words, the electronic controller 12 may employ standard motordriving techniques to drive the motor 10 to achieve the oscillationpatterns.

Referring now to FIGS. 9A-9D, an oscillation pattern 900 is illustrated.The oscillation pattern 900 may be implemented by the electroniccontroller 12 (driving the motor 10) to oscillate the HFMs 34, forexample, to implement block 815 of the process 800. The oscillationpattern 900 is an oscillation pattern without superimposed oscillations(such as described below). In FIGS. 9A-9D, a rotation axis 905 mayrepresent a drive shaft 11 or center axis of the HFMs 34 (e.g., thecentral shaft 228), and the HFM 910 may represent a single HFM withinthe HFMs 34. Additionally, the other HFMs within the HFMs 34 may bepresumed to rotate similarly to the HFM 910 (although each is offsetfrom the HFM 910 and will have a unique position during theoscillations). As illustrated, the oscillation pattern 900 includes anoscillation of 180 degrees, made up of steps (α) of 90 degrees. That is,the axis 905 (and HFM 910) rotates 90 degrees clockwise from a position1 to position 2 in FIG. 9A, rotates 90 degrees clockwise from position 2to a position 3 in FIG. 9B, rotates 90 degrees counterclockwise fromposition 3 to position 4 in FIG. 9C, and rotations 90 degreescounterclockwise from position 4 to position 5 in FIG. 9D. In someexamples, the electronic controller 12 may repeat the pattern of FIGS.9A-9D, causing the axis 905 (and HFM 910) to continue to oscillate 180degrees from position 1 to position 3. In some examples, the motor 10may pause the rotation of the axis 905 at each position 1, 2, 3, 4, and5 before continuing to rotate the axis 905 to the next position. In someexamples, the motor 10 does not pause at each position (but for aninherent pause to reverse direction at positions 1, 3, and 5). In someexamples, the oscillation pattern 900 is modified to have an oscillationof more than 180 degrees or less than 180 degrees (e.g., a value between5 and 360 degrees, between 5 and 180 degrees, between 5 and 90 degrees,between 5 and 22.5 degrees, between 22.5 and 45 degrees, etc). The stepsa may also be referred to as oscillation steps or increments.

Referring now to FIGS. 9E-9H, an oscillation pattern 915 is illustratedwith respect to the rotation axis 905 and HFM 910. The oscillationpattern 915 may be implemented by the electronic controller 12 (drivingthe motor 10) to oscillate the HFMs 34, for example, to implement block815 of the process 800. The oscillation pattern 900 is an oscillationpattern with superimposed oscillations including macro-oscillations andmicro-oscillations occurring at steps of the macro-oscillations. Asillustrated, the oscillation pattern 915 includes a macro-oscillation of180 degrees, made up of steps (α) of 90 degrees, and micro-oscillationsof approximately 22.5 degrees. Specifically, FIG. 9E shows a 90-degreeclockwise rotation of the rotation axis 905 (and HFM 910) from positionone to position two. FIG. 9F shows an example of micro-oscillations ofan angle β centered at position 2, as indicated by the directionalarrows. FIG. 9G shows a 90-degree clockwise rotation of the rotationaxis 905 (and HFM 910) from position two to position three. FIG. 9Hshows another example of micro-oscillations of the angle β centered atposition 3, as indicated by the directional arrows. To complete themacro-oscillation, the motor 10 further rotates the rotation axis 905(and HFM 910) to rotate back to position 1. In some examples, the motor10 rotates the axis 905 counterclockwise 180 degrees directly back toposition 1 without additional steps a (e.g., without stopping atposition 2). In other examples, the motor 10 rotates the axis 905 (andthe HFM 910) counterclockwise a step a (e.g., 90 degrees) back toposition 2, and the oscillates the rotation axis 905 (and HFM 910) tocause micro-oscillations of the angle β at position 2, before continuingon to return to position 1. In some examples, the particular angle ofmicro-oscillations may vary after each of the one or more of the stepsα, but may be at least β. In some examples, the pattern 915 includesadditional or fewer steps α, larger or smaller steps α, and/or amacro-oscillation of a greater or smaller angle than 180 degrees.

Referring now to FIG. 10 , an oscillation pattern 1000 is illustrated inthe form of a plot of rotation angle (e.g., of the HFMs 34, centralshaft 228, drive shaft 11, etc.) versus time. The oscillation pattern1000 may be implemented by the electronic controller 12 (driving themotor 10) to oscillate the HFMs 34, for example, to implement block 815of the process 800. The oscillation pattern 1000 is another oscillationpattern with superimposed oscillations including macro-oscillations andmicro-oscillations occurring between steps a of the macro-oscillations.The oscillation pattern 1000 includes 180 degree macro-oscillations with45 degree steps a separated every 1 second. After each step, theoscillation pattern 1000 includes 22.5 degree micro-oscillations (i.e.,β equals 22.5 degrees). In this example, the rotation for themicro-oscillations and steps occur at an angular velocity of 3200degrees/second. In some examples, characteristics of the oscillationpattern 1000 may be modified. For example, the pattern 1000 may includeadditional or fewer steps α, larger or smaller steps a, amacro-oscillation of a greater or smaller angle than 180 degrees, and/ormay rotate with a different or varying angular velocity.

FIGS. 11A-K illustrate further examples of rotational oscillationpatterns in the form of a plot of rotation angle (e.g., of the HFMs 34,central shaft 228, drive shaft 11, etc.) versus time, similar to theplot of FIG. 10 . These further examples of oscillation patterns mayalso be implemented by the electronic controller 12 (driving the motor10) to oscillate the HFMs 34, for example, to implement block 815 of theprocess 800. Additionally, similar to the pattern 1000 of FIG. 10 , themotor 10 may be driven to cause the illustrated patterns of FIGS.11A-11K to repeat multiple times (e.g., continuously) during operationof the oxygenation system 200 or 100 (e.g., in block 815 of the process800).

Starting with FIG. 11A, an oscillation pattern 1100 is provided that hasconstant rotational velocity. In particular, FIG. 11A shows theoscillation pattern 1100 having a constant macro-oscillation velocityduring steps α and a constant micro-oscillation velocity duringmicro-oscillations (having angle β). Turning to FIG. 11B, an oscillationpattern 1105 having a macro-oscillation velocity during steps α that isdifferent than a micro-oscillation velocity during micro-oscillations(having angle β). In particular, the micro-oscillation velocity ishigher (faster) than the macro-oscillation velocity in the oscillationpattern 1105. In other examples, the oscillation pattern 1105 includes amicro-oscillation velocity that is lower (slower) than themacro-oscillation velocity. In the oscillation pattern 1105, themacro-oscillation velocity is constant across steps α and themicro-oscillation velocity is constant for each set ofmicro-oscillations. In other examples of the oscillation pattern 1105,one or more of the steps α may have a different macro-oscillationvelocity than other steps α and/or one or more set of micro-oscillationsmay have a different micro-oscillation velocity than other sets ofmicro-oscillations.

FIG. 11C shows an oscillation pattern 1110 having a constantmacro-oscillation velocity and micro-oscillation velocity, similar topattern 1100 of FIG. 11A. However, in contrast to the pattern 1100, thepattern 1110 has macro-oscillations with steps α that are larger thanthe angle β of the micro-oscillations. FIG. 11D shows an extendedversion of the oscillation pattern 1110 shown in FIG. 11C.

FIG. 11E shows an oscillation pattern 1120 having a constantmacro-oscillation velocity and micro-oscillation velocity, similar topattern 1100 of FIG. 11A. However, in contrast to the pattern 1100, thepattern 1120 is a homing pattern such that, after reaching the maximumrotational angle of the macro-oscillation (e.g., 180 degrees), the motor10 rotates the HFMs 34 back to the starting position (e.g., 0 degrees)without intermediate steps a and micro-oscillations. In other words, themotor 10 superimposes micro-oscillations on the macro-oscillation of theHFMs 34 during one rotational direction of the macro-oscillation (e.g.,clockwise), but not on the return rotational direction (e.g.,counterclockwise) of the macro-oscillation. FIG. 11F shows an extendedversion of the homing oscillation pattern 1120 shown in FIG. 11F.

FIG. 11H shows a sawtooth oscillation pattern 1125 configured provide asawtooth motion comprising a macro-oscillation including steps α with asingle micro-oscillation after each step α on route from the startingangular position to the ending angular position of the macro-oscillation(i.e., from 0 degrees to 180 degrees). The sawtooth oscillation pattern1125 in FIG. 11H also has a homing pattern in that the motor 10 rotatesthe HFMs 34 back to the starting angular position (e.g., 0 degrees) fromthe ending angular position (180 degrees) of the macro-oscillationwithout intermediate steps α and micro-oscillations. FIG. 11I shows anextended version of the sawtooth oscillation pattern 1125 shown in FIG.11H.

FIG. 11J shows an oscillation pattern 1130 having a constantmacro-oscillation velocity and micro-oscillation velocity, similar topattern 1100 of FIG. 11A. However, in contrast to the pattern 1100, thepattern 1130 having only two micro-oscillations after each step α.

FIG. 11K shows an oscillation pattern 1135 that is configured to userandom angles of oscillation. To implement the random oscillationpattern 1135, the electronic controller 12 may randomly select, at eachvertex (or step) in the pattern, a rotational angle indicating arotation amount and velocity indicating a rotational velocity to drivethe motor 10 to the next vertex (with the rotation direction alternatingbetween each vertex or step). The electronic controller 12 may selectthe rotational angle and velocity by executing various known randomnumber generators or algorithms that are bounded with acceptable rangesfor rotational angles and velocities for the oscillation pattern 1135.

The example oscillation patterns provided with respect to FIGS. 9Athrough 11K are non-limiting and can be used separately or in anycombination by the systems described herein (including systems 100 and200) to oscillate the HFMs 34. Additionally, the systems describedherein may use other oscillation patterns not explicitly describedherein to oscillate the HFMs 34.

Referring now to FIG. 12 , a catheter 20 f is illustrated. The catheter20 f is another embodiment of the catheter 20 referenced herein. Thecatheter 20 f may be similar to the catheter 20 c, except for anydifferences noted herein. In some embodiments, the oxygenation system100 or 200 includes the catheter 20 f as the catheter 20. Accordingly,the catheter 20 f may be used by the systems 100 or 200 in implementingthe process 800 of FIG. 8 . In contrast to the catheter 20 c, thecatheter 20 f includes a protective outer sheath 1200 as a protectiveguard in place of the protective guard 280. The HFMs 34 are entirelycontained within the protective outer sheath 1200, and the protectiveouter sheath 1200 extends between a proximal end tip 242 and a distalend tip 244. The protective outer sheath 1200 may be coupled to theproximal end tip 242 and the distal end tip 244 similar to the manner inwhich the guard 280 is coupled to the end tips 242, 244, as describedabove, such that the protective sheath 1200 may be static (not rotating)while the HFMs 34 are oscillated.

The protective outer sheath 1200 may contain blood inlets 1210 atproximal and distal ends of the sheath that are configured to urge bloodinward towards the HFMs. The protective outer sheath 1200 also maycontain blood outlets 1220 located between the proximal and distal endof the sheath that are configured to expel oxygenated blood outward inan area of interest of a subject. In some aspects, the protective outersheath 1200 does not have any openings on its surface other than theblood inlets 1210 and blood outlets 1220. During operation of the system100 or 200 utilizing the catheter 20 f, blood is urged inward tointeract with the oscillating HFMs 34 within the protective outer sheath1200 to be oxygenated, and then expelled outward via the blood outlets1220 in the area of interest of the subject. In some examples, amicro-axial pump (see, e.g., pump 360 of FIG. 13 ) is provided withinthe protective sheath 1200 to provide urging forces to urge blood inthrough the blood inlets 1210 and to expel the oxygenated blood outthrough the blood outlets 1220. In some examples, the HFMs 34 areconfigurated such that the oscillation thereof provides urging forces tourge blood in through the blood inlets 1210 and to expel the oxygenatedblood out through the blood outlets 1220 (see, e.g., discussion of HFMswith respect to FIGS. 14-17H below).

Referring now to FIG. 13 , a catheter 20 g is illustrated. The catheter20 g is another embodiment of the catheter 20 referenced herein. Thecatheter 20 g may be similar to the catheter 20 f, except for anydifferences noted herein. In some embodiments, the oxygenation system100 or 200 includes the catheter 20 g as the catheter 20. Accordingly,the catheter 20 g may be used by the systems 100 or 200 in implementingthe process 800 of FIG. 8 . In contrast to the catheter 20 f, thecatheter 20 g includes a flexible joint 1350 that can join at least aplurality of first HFMs 1330 with a plurality of second HFMs 1340. TheHFMs 1330 and 1340 may each be an example of a bundle of HFMs 34, suchas previously described. The flexible joint 1350 can contain amicro-axial pump 1360 that can pull blood in through blood inlets 1310of a protective sheath 1300 and through the pluralities of HFMs 1330 and1340. The flexible joint 1350 can be connected to a distal end of aplurality of first HFMs 1330 and connected to a proximal end of aplurality of second HFMs 1340, or the flexible joint 1350 can beconnected to the pluralities of HFMs in various other combinations.Additionally, the micro-axial pump 360 can be configured to pump bloodthrough the pluralities of HFMs and urge oxygenated blood outwardthrough blood outlets 1320 of the protective sheath 1300 (e.g., towardsa tricuspid valve of a subject). The protective sheath 1300 may begenerally similar to the protective sheath 1200 of FIG. 12 , exceptextended to cover each set of HFMs 1330 and 1340 and for differentlocations of the inlets 1310 and outlets 1320.

Referring now to FIG. 14 , a cross-sectional view of a spacing mechanism1400 is shown. The spacing mechanism 1400 may be used in conjunctionwith the HFMs 34 in the various embodiments provided herein, includingas part of the various catheters 20 and systems (e.g., systems 100 and200) provided herein. The spacing mechanism 1400 can include at leastone spiral support member 1410 that is connected to the central shaft228 at an attachment point 1415 (e.g., via an adhesive). In theillustrated spacing mechanism 1400 includes two spiral support members1410, although only one or more than two spiral support members 1410 areused in other examples. Each spiral support member 1410 is configured toretain a subset of the HFMs 34 in a spiral configuration relative to thecentral shaft 228, where the HFMs 34 generally extend parallel to oneanother. For example, the spiral support member(s) 1410 may include aweave (e.g., of interwoven fibers) through which the HFMs 34 pass and bywhich the HFMs 34 are retained. Additionally, in some examples, thespiral support member(s) 1410 retain their respective HFMs 34 in anon-woven configuration.

FIGS. 15A-15B provide partial perspective views of the spacing mechanism1400 used with the HFMs 34 in two different states, a scooping state(FIG. 15A) and a squeezing state (FIG. 15B). The spiral support members1410 of the spacing mechanism 1400 are no illustrated in FIGS. 15A and15B, but the spiral arrangement of the two subsets of HFMs 34 resultingfrom the two spiral support members 1410 is illustrated. Duringoscillation of the HFMs 34 (e.g., in block 815 of process 800), the atleast one spiral support member 1410 can be driven by the motor 10 torotate in a first direction such that the at least one spiral supportmember 1410 expands radially outward and arranges the subset(s) of HFMs34 in a scooping state. This scooping state can cause blood to be drawnin an inward radial direction towards the central shaft 228 to exposethe drawn-in blood to the HFMs 34 to enable diffusive flux of oxygeninto the drawn-in blood. Additionally, the at least one spiral supportmember 1410 can be driven by the motor 10 to rotate in a seconddirection such that the at least one spiral support member 1410contracts radially inward and arranges the subset(s) of HFMs 34 in asqueezing state. This squeezing state can cause blood to be urged in anoutward radial direction away from the central shaft 228. The scoopingcan increase the blood that is exposed to the HFMs 34 and the squeezingcan increase the oxygenated blood exhausted away from the HFMs 34 backinto an area of interest of a subject. By oscillating the spacingmechanism 1400 (and, thereby, the HFMs 34) by the motor 10, the HFMs 34alternate between a scooping and squeezing state, which increases theflow of blood in and out of proximity and interaction with the HFMs 34.Accordingly, the alternating scooping and squeezing states can increasethe diffusive flux of the oxygenated gas from the HFMs 34 to the bloodin a region of interest of a subject.

FIG. 16 shows an example sawtooth oscillation pattern 1600, similar tothe sawtooth oscillation pattern 1125 of FIGS. 11H and 11I, that can beused to induce the scooping and squeezing states described above. Inother examples, the motor 10 oscillates the spacing mechanisms 1400 (andHFMs 34) to induce the scooping and squeezing states using anotheroscillation pattern, such as one of the other oscillation patternsprovided herein. In this example, the macro-oscillation steps a caninduce expansion of the at least one spiral support member 1410 toresult in the scooping state, and the micro-oscillations can induceretraction to result in the squeezing state. One skilled in the art willreadily appreciate that this example is non-limiting and any number ofoscillation patterns may be used to induce the rotational motion definedby the scooping and squeezing states. Additionally, in other aspects,the macro-oscillation steps may induce squeezing and themicro-oscillations may induce scooping, or another combination of macro-and micro-oscillations can be used to cause rotational motion of the atleast one spiral support member 1410.

FIGS. 17A-H illustrate various arrangements of the at least one spiralsupport members 1410 of the spacing mechanism 1400 that may be used toarrange the HFMs 34. FIG. 17A shows an example spiral arrangement of asingle spiral support member connected to the central shaft 228. FIG.17B shows an example spiral arrangement of two spiral support membersconnected to the central shaft 228. FIG. 17C shows an example spiralarrangement of three spiral support members connected to the centralshaft 228. FIG. 17D shows an example half wrap spiral arrangement of onespiral support member connected to the central shaft 228. FIG. 17E showsan example triple wrap spiral arrangement of one spiral support memberconnected to the central shaft 228. FIG. 17F shows an example compressedtriple wrap spiral arrangement of one spiral support member connected tothe central shaft 228. 17G shows an example half wrap spiral arrangementof two spiral support members connected to the central shaft 228. FIG.17H shows an example triple wrap spiral arrangement of two spiralsupport members connected to the central shaft 228. FIG. 17I shows anexample compressed triple wrap spiral arrangement of two spiral supportmembers connected to the central shaft 228. One skilled in the art willreadily appreciate that these examples are non-limiting and any numberof spiral support members may be used to arrange the HFMs 34. In otheraspects, arrangements other than spiral arrangements can be used toarrange the HFMs 34.

The disclosed systems and methods that include oscillating HFMs canimprove oxygen mass transfer in a subject by both disrupting liquidboundary layer formation external to the hollow fibers and by increasingthe exposure of fibers to differing areas of bulk fluid in the system.The oscillations, including those oscillation patterns with superimposedangular oscillations, combined with the hyperbaric membrane approach canresult in oxygen transfer efficiencies greater than any previouslyreported in the literature.

In an example embodiment, the systems provided herein (also referred toas IntraVascular Membrane Oxygenators (IVMOs)), are intended to deliveroxygen, the primary deficit in most forms of acute lung injury. Thedisclosed systems and methods can require less total HFM surface areaand allow for a more compact device amenable to intravascular use,overcoming challenges faced by previous groups.

Referring now to FIG. 18 , a schematic diagram of an experimentalcircuit 1800 used for HFM experimentation is shown. Specifically, theexperimental circuit 1800 was built to test the impact of oscillation onoxygen flux from hollow fiber membranes (HFMs) that have high-pressureoxygen flowing through their lumens. The HFMs are located in the reactorand are attached to a stepper motor via a rotary shaft. High pressureoxygen flows through the HFM loops as water as a test fluid forexperimentation (or blood in clinical cases) flows past at varyingspeeds. The increase in dissolved oxygen in the water (or blood) ismeasured. An ECMO membrane with nitrogen flowing through in series isused to de-oxygenate the water to the desired baseline for experimentalpurposes.

FIG. 19 shows the results of the experimentally determined oxygen fluxat selected angular speeds of oscillation. The panel on the leftrepresents a 32 fiber bundle oscillating back and forth 180 degrees (atvarious speeds as indicated by mixes 1, 2, 3). The panel on rightrepresents the fiber bundle oscillating with macro-oscillations of 180degrees in 22.5 degree increments (steps α=22.5 degrees) with 11.5degree micro-oscillations (β=11.5 degrees) superimposed, and executed atvarious speeds as indicated by mixes 5, 6, 7. Specifically, the mixingregimes were at high (1.345 bar absolute pressure (0.345 barg)) and low(1.147 bar absolute pressure (0.147 barg)) pressures under two flowconditions (0.5 and 2.0 LPM) with mixing regimes 1 through 3, and 5through 7 being 3200, 1600, 720 degrees/second, respectively, using thedescribed oscillation. Experiments were performed in water at 37 degreeC., with a viscosity of 3.5 cP, and flowing through the mock vena cavareactor at both 0.5 and 2 liters/minute to mimic physiologic conditions.The resulting data shows that oxygen flux increases with increasedangular speed of the oscillations, and that rotational oscillationprovides much improved oxygen flux compared to static fibers. Further,only a slight decrease in oxygen flux was observed for the mixes 5, 6,and 7, relative to mixes 1, 2, and 3, resulting from the superimposedmicro-oscillations. Additionally, oscillations of HFMs, and even more sooscillations with superimposed micro-oscillations, provide reducedbubble generation, as discussed further with respect to FIG. 20 , andthe slight decrease in flux from superimposed micro-oscillations can bemitigated by increasing the oscillation speed.

FIG. 20 shows the results of the experimentally determined number ofbubbles for a single loop of fiber C (34 cm total length in correlationwith the average gage fiber pressure). Experiments were performed at 0.5LPM system flow rate under 4 mixing regimes. Mixes 1 and 3 wererotationally oscillated 180 degrees, without micro-oscillation, at 3200and 720 degrees/second respectively. Mixes 5 and 7 were rotationallyoscillated at 3200 and 720 degrees/second, respectively, withmacro-oscillations of 180 degrees in 22.5 degree increments (i.e., stepsα=22.5 degrees) with 11.5 degree micro-oscillations (β=11.5 degrees)superimposed at each step. Decreased bubble formation was found to occurwhen micro-oscillations were superimposed upon macro-oscillations (mixes5 and 7). Accordingly, by superimposing micro-oscillations uponmacro-oscillations, bubble formation is decreased and/or eliminated. Thereduction in bubbles, in turn, enables operation of the oxygenationsystem (e.g., system 100 or 200) at higher intraluminal pressure (i.e.,the oxygenated gas can be at a higher pressure), which results inincreased diffusive flux of oxygen. At least in some examples, withoutthis superimposed micro-oscillation technique, bubble formation mayincrease to an undesirable level at these higher intraluminal pressures,thereby preventing a system from increasing the pressure of theoxygenated gas to achieve a desired diffusive flux of oxygen. Statedanother way, generally, as pressure of the oxygenated gas in the HFMs 34increases, diffusive flux of oxygen increases and bubble formationincreases. However, oscillating the HFMs 34, particularly rotationallyoscillating the HFMs 34 with micro-oscillations superimposed onmacro-oscillations, reduces the bubble formation, thereby enabling anincrease in the pressure of the oxygenated gas and in the resultingdiffusive flux of oxygen into blood without the corresponding increasein bubbles.

FIG. 21 shows experimentally determined oxygen flux of a hollow fiberbundle prototype (total diffusing surface area of 0.22 m²) undergoingsuperimposed angular oscillations (macro-oscillations with step α at22.5 degrees, micro-oscillations with angle β at 45 degrees, angularvelocity 3200 degrees/second). Experiments were performed in vitro usingporcine whole blood flowing at 3 L min−1 in accordance with ISO 7199.Increased oxygen flux was found to occur at higher intraluminal absoluteoxygen pressures.

FIG. 22 shows an experimentally determined normalized index of hemolysisof a hollow fiber bundle prototype (total diffusing surface area of 0.22m²) undergoing superimposed angular oscillations (macro-oscillationswith step α at 22.5 degrees, micro-oscillations with angle β at 45degrees, angular velocity 3200 degrees/second). Experiments wereperformed in vitro using porcine whole blood flowing at 3 liters/minutein accordance with the American Society for Testing and Materials (ASTM)standard F1841-19. The rate of hemolysis attributed to catheterprototype using this experimental setup was found to be within aclinically acceptable range (<0.05 g/100 L).

In a series of experiments, the hyperbaric approach to membraneoxygenation with HFMs in combination with oscillating the HFMs wastested. Active mixing was accomplished using superimposed angularoscillation of the HFM bundle, as described herein. The HFM bundle wassecured to a central shaft that was rotated at various speeds over 180degrees of total rotation arc. A stepper motor and controller were usedto set the motor's rotational speed (degrees/second), total arctraveled, and oscillation settings. The bundles of fiber were created tofit within a 1.5 cm diameter using a mesh spacer at two locations.Travel of an individual fiber is illustrated for macro steps over angleα followed by micro-oscillations over angle β. When this system wastested under physiologic conditions (2 L/min flow of aqueous PEGsolution to match viscosity of whole blood at 3.5 cP and 37° C.) itdelivered approximately 300 mL O₂/(min*m²) at only 5 PSI (or 1.345 bar)intraluminal oxygen pressure. This result was an approximately 100%increase in flux when compared to the static fibers in earlier testing.When a thinner wall fiber (OD 305 μm with 38 μm wall thickness) was usedat the same low intraluminal pressures (5 PSI, 1.345 bar) the oxygenflux increased to 400 mL O₂ min−1 m−2, surpassing even that of thepresent previous high pressure (27.5 PSI, 2.9 bar) static tests.

FIG. 23 is a process schematic of a benchtop experimental setup fortesting in porcine blood. This setup included an ex vivo benchtopcircuit 2300 capable of mimicking intravascular conditions in accordancewith ISO 7199. The HFM bundles were placed in the 2 cm ID reactor andoscillated by a stepper motor and controller so that it was possible toset the motor's rotational speed (degrees/second), total arc traveled,and oscillation settings, similar to the present previous work. Porcinewhole blood collected via venipuncture from donor animals was obtainedand used within 48 hours of collection. Blood was pumped past the hollowfiber bundle reactor at 3 L/min and inlet blood conditions were heldconstant in accordance with ISO 7199 (temperature 37° C., %oxyhemoglobin saturation 65±5, base excess 0±5 mmol/L, PaCO2 45±5 mmHg)using a membrane oxygenator (Maquet/Getinge AB, Goteborg, Sweden) with acustom blend sweep gas. Inlet and outlet blood gas samples were takenand analyzed using a GEM Premiere 3000 blood gas analyzer (Werfen,Bedford, Mass.) and Avoximeter 4000 (Werfen, Bedford, Mass.). A TeflonAF 2400 hollow fiber bundle composed of 68 fibers (32.8 cm in length)using fibers (OD of 254 μm and 38.1 μm wall thickness) was tested. TheHFM bundle was made to fit within a 2 cm diameter using a mesh spacer atthree locations. When placed in porcine whole blood with hemoglobinvalues between 9 and 11 g/dL value of, and with an average intraluminaloxygen pressure of 1.1 to 1.7 bar absolute , oxygen flux averagesranging from 336 to 552 mL O₂/(min*m²), were observed. A maximum of 708mL O₂/(min*m²) was observed at 1.6 bar absolute oxygen pressure.

These series of experiments demonstrate the high oxygen transferefficiency (oxygen flux) of the present novel approach to membraneoxygenation. By combining a high-pressure oxygen gradient acrossnon-porous HFMs undergoing oscillation (e.g., according to one of theoscillation patterns provided herein), the systems and methods are ableto reduce the impacts of both internal and external barriers to oxygenmass transfer and can achieve oxygen fluxes higher than those reportedin the literature. When tested in blood under the conditions describedabove, the system demonstrates on average over a 150% increase in oxygenflux compared to the IVOX device that was tested in human clinicaltrials (552 mL O₂/(min*m²) vs 219 mL O₂/(min*m²) and a 23% increase uponthe highest oxygen flux previously reported in the literature for anyintravascular gas exchange device (552 mL O₂/(min*m²) vs 450 mLO₂/(min*m²) reported by the group developing the HIMOX device.

Flux efficiency achieved in previous work by Hattler et al. with extrememixing (10,000 RPM) and more modest balloon pulsing methods (300 BPM)resulted in maximum flux of around 374 mL O₂/(min*m²) and 140 mLO₂/(min*m²), respectively. In experiments using approaches providedherein, with oscillation of HFMs at oxygenated gas at 1.1 bar absolutepressure or more, the oxygen flux exceeded previous work by Hattler etal. and the present inventors using static HFM diffusive flux, resultingin flux efficiencies of 500 mL O₂/(min*m²) and above. For example, intesting with a system similar to the system 200 with the catheter 20 c,with average intraluminal oxygen pressure of 1.1 to 1.7 bar absolute,oxygen flux averages ranged from 336 to 552 mL O₂/(min*m2), and amaximum of 708 mL O₂/(min*m2) was observed at 1.6 bar absolute oxygenpressure. In these tests, the HFMs 34 were oscillated with anoscillation pattern having macro-oscillations including steps α withangle of 22.5 degrees and micro-oscillations with β angle of 45 degrees(at 3200 degrees per second). These results show a significantimprovement in oxygen flux (approximately 150% of the flux of Hattler etal.) when the system operates at 1.6 bar and with greatly reducedrotation speeds. More particularly, the example rotation speeds toproduce the oscillations in the tests were only approximately 533 RPM inwhole blood, compared to 10,000 RPM. Accordingly, the results illustratea significant improvement in flux with significantly less mixing, whichimproves biocompatibility of the system with a subject.

Accordingly, oxygenation systems and methods provided herein usehyperbaric intraluminal oxygen pressure, which enables high diffusionthrough HFMs, combined with oscillations of the HFMs that increase theefficiency of the diffusion through the HFMs relative to static HFMs. Insome examples, micro-oscillations are superimposed on the oscillations(i.e., on oscillations of larger angles, also referred to asmacro-oscillations), which can ensure that oxygen in the HFMs that isdiffused through the HFMs is dissolved into solution (into a subject'sblood) with decreased or no bubble formation. Because these oscillationtechniques decrease or eliminate bubbles, the HFMs can operate athyperbaric pressure and at higher levels than previously employable.Further, because higher pressure levels can be used, an increase inoxygen flux and transfer efficiency results. Further, the increasedoxygen flux and transfer efficiency (using hyperbaric pressure andoscillation) enables reduction in gas diffusing surface area of theHFMs. In other words, the size of the HFM bundle may be more compactand, thus more amenable to intravascular use.

It is to be understood that the ranges described herein are non-limitingexample ranges. Input parameters such as the rotation speed, angle ofrotation, and time between oscillations can be varied in order tooptimize the bubble reduction and increase oxygen flux for a particularsubject.

One skilled in the art will readily appreciate that the presentdisclosure is well adapted to carry out the objects and obtain the endsand advantages mentioned, as well as those inherent therein. The presentdisclosure described herein are presently representative of preferredembodiments, are exemplary, and are not intended as limitations on thescope of the present disclosure. Changes therein and other uses willoccur to those skilled in the art which are encompassed within thespirit of the present disclosure as defined by the scope of the claims.

No admission is made that any reference, including any non-patent orpatent document cited in this specification, constitutes prior art. Inparticular, it will be understood that, unless otherwise stated,reference to any document herein does not constitute an admission thatany of these documents forms part of the common general knowledge in theart in the United States or in any other country. Any discussion of thereferences states what their authors assert, and the applicant reservesthe right to challenge the accuracy and pertinence of any of thedocuments cited herein. The present disclosure shall control in theevent there are any disparities between any definitions and/ordescription found in any incorporated references.

1. An intravascular oxygenation system, the system comprising: apneumatic inlet configured to couple to a pneumatic source that providesa gas containing oxygen at a pressure at or above 1.1 bar of absolutepressure; a plurality of hollow fiber membranes (HFM) in pneumaticcommunication with the pneumatic inlet to receive the gas containingoxygen and with an outlet to exhaust deoxygenated gas; a motor coupledto the plurality of HFMs; and an electronic controller coupled to themotor and configured to drive the motor to oscillate the plurality ofHFMs to cause a diffusive flux of the gas containing oxygen from theplurality of HFMs in a region of interest of a subject.
 2. Theintravascular oxygenation system of claim 1, wherein, to drive the motorto oscillate the plurality of HFMs, the electronic controller isconfigured to drive the motor to provide superimposed angularoscillations to the plurality of HFMs including macro-oscillations,comprised of steps α, superimposed with micro-oscillations with at leastan oscillation angle of β.
 3. The intravascular oxygenation system ofclaim 2, wherein α is in a range of approximately 1-360 degrees, and βis in a range of approximately 1-180 degrees, and wherein the gascontaining oxygen is at a pressure at or between 1.1 bar and 5.0 bar ofabsolute pressure.
 4. The intravascular oxygenation system of claim 2,wherein, to provide the superimposed angular oscillations to theplurality of HFMs, at each step α of the macro-oscillations, theelectronic controller is configured to drive the motor to oscillate withthe micro-oscillations with at least the oscillation angle of β todefine an oscillation pattern.
 5. The intravascular oxygenation systemof claim 2, wherein the superimposed angular oscillations reduce bubbleformation in the region of interest of the subject.
 6. The intravascularoxygenation system of claim 1, wherein, to drive the motor to oscillatethe plurality of HFMs, the electronic controller is configured to drivethe motor to oscillate with random angles of oscillations.
 7. Theintravascular oxygenation system of claim 1, wherein the intravascularoxygenation system is configured to achieve a diffusive flux of the gascontaining oxygen at or above 500 mL per minute per square meter.
 8. Theintravascular oxygenation system of claim 1, wherein the plurality ofHFMs are compressed by one or more of a retractable sheath or from beingwound around a central shaft to define a travelling state conformation,and wherein, to release the plurality of HFMs to define a deployed stateconformation, one or more of the retractable sheath is retracted or theplurality of HFMs are unwound.
 9. The intravascular oxygenation systemof claim 1, wherein the plurality of HFMs is disposed within aprotective guard comprising a mesh cage.
 10. The intravascularoxygenation system of claim 9, further comprising a catheter shafthaving a wall that extends along a longitudinal axis to define a lumenin which the pneumatic inlet and exhaust are provided; and a retractablesheath defining a traveling state conformation when positioned over theplurality of HFMs and the protective guard and defining a deployed stateconformation when retracted along a length of the catheter shaft. 11.The intravascular oxygenation system of claim 1, further comprising: aproximal end tip and a distal end tip, the plurality of HFMs extendingbetween the proximal end tip and the distal end tip, the proximal endtip retaining proximal ends of the plurality of HFMs and the distal endtip retaining distal ends of the plurality of HFMs.
 12. Theintravascular oxygenation system of claim 11, further comprising: acentral shaft extending between the proximal end tip and the distal endtip, the central shaft coupled to the pneumatic inlet to receive the gascontaining oxygen, the gas containing oxygen traveling through thecentral shaft from the proximal end tip to the distal end tip, thecentral shaft providing the gas containing oxygen to inlets of theplurality of HFMs at the distal end tip.
 13. The intravascularoxygenation system of claim 1, further comprising a central shaftextending between a proximal end tip and a distal end tip; and a spiralsupport member configured to retain a subset of the plurality of HFMs ina spiral configuration, wherein when, as a first part of an oscillationof the plurality of HFMs, the motor drives the plurality of HFMs torotate in a first direction, the spiral support member expands radiallyoutward to arrange the subset of HFMs into a scooping state that drawsblood towards the central shaft; and when, as a second part of theoscillation of the plurality HFMs, the motor drives the plurality ofHFMs to rotate in a second direction, the spiral support membercontracts radially inward to arrange the subset of HFMs into a squeezingstate that urges blood away from the central shaft.
 14. Theintravascular oxygenation system of claim 1, further comprising: avacuum system pneumatically coupled to the plurality of HFMs, whereinthe electronic controller is further configured to control the vacuumsystem to de-pressurize the HFMs in response to determining a loss ofpressure in the HFMs exceeding a threshold.
 15. A method forintravascular oxygenation, the method comprising: receiving, by apneumatic inlet coupled to a pneumatic source, a gas containing oxygenat a pressure at or above 1.1 bar of absolute pressure; receiving, by aplurality of hollow fiber membranes (HFM) in pneumatic communicationwith the pneumatic inlet, the gas containing oxygen; and driving, by anelectronic controller, a motor to oscillate the plurality of HFMs tocause a diffusive flux of the gas containing oxygen from an interior ofthe plurality of HFMs in a region of interest of a subject.
 16. Themethod of claim 15, wherein driving the motor to oscillate the pluralityof HFMs comprises driving the motor, by the electronic controller, toprovide superimposed angular oscillations to the plurality of HFMsincluding macro-oscillations, comprised of steps α, superimposed withmicro-oscillations with at least an oscillation angle of β.
 17. Themethod of claim 15, the method further comprising: compressing, by oneor more of a retractable sheath or a rotational winding of the pluralityof HFMs around a central shaft, the plurality of HFMs to define atravelling state conformation; and deploying the plurality of HFMs to adeployed state conformation by one or more of retracting the retractablesheath or rotationally unwinding the plurality of HFMs.
 18. The methodof claim 15, wherein driving the motor to rotationally oscillate theplurality of HFMs comprises: driving the motor, by the electroniccontroller, to rotate the plurality of HFMs in a first direction toexpand a spiral support member in an outward radial direction to arrangea subset of the plurality of HFMs into a scooping state that draws bloodtowards a central shaft; and driving the motor, by the electroniccontroller, to rotate the plurality of HFMs in a second direction and tocontract the spiral support member in an inward radial direction toarrange the subset of the plurality of HFMs into a squeezing state thaturges blood away from the central shaft.
 19. The method of claim 15,further comprising: receiving, from the pneumatic inlet, the gascontaining oxygen by a central shaft extending between a proximal endtip and a distal end tip; retaining, by the proximal end tip, proximalends of the plurality of HFMs; and retaining, by the distal end tip,distal ends of the plurality of HFMs.
 20. The method of claim 15,wherein the plurality of HFMs is disposed within a protective guardcomprising a mesh cage.